Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Drug Resistance

  Free Subscription


Articles published in J Antimicrob Chemother

Retrieve available abstracts of 393 articles:
HTML format
Text format



Single Articles


    June 2018
  1. TORUMKUNEY D, Nica M, Nistor I, Vatcheva-Dobrevska R, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Bulgaria, Romania, Serbia and Croatia.
    J Antimicrob Chemother. 2018 Jun 12. pii: 5036449. doi: 10.1093.
    PubMed     Text format    


  2. TORUMKUNEY D, Pertseva T, Bratus E, Dziublik A, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Ukraine and the Slovak Republic.
    J Antimicrob Chemother. 2018 Jun 12. pii: 5036451. doi: 10.1093.
    PubMed     Text format    


  3. ZONG Z, Fenn S, Connor C, Feng Y, et al
    Complete genomic characterization of two Escherichia coli lineages responsible for a cluster of carbapenem-resistant infections in a Chinese hospital.
    J Antimicrob Chemother. 2018 Jun 11. pii: 5035906. doi: 10.1093.
    PubMed     Text format     Abstract available


  4. FARKAS A, Sassine J, Mathew JP, Stavropoulos C, et al
    Outcomes associated with the use of a revised risk assessment strategy to predict antibiotic resistance in community-onset pneumonia: a stewardship perspective.
    J Antimicrob Chemother. 2018 Jun 11. pii: 5035907. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2018
  5. LIN JN, Lai CH, Yang CH, Huang YH, et al
    Clinical manifestations, molecular characteristics, antimicrobial susceptibility patterns and contributions of target gene mutation to fluoroquinolone resistance in Elizabethkingia anophelis.
    J Antimicrob Chemother. 2018 May 28. pii: 5017392. doi: 10.1093.
    PubMed     Text format     Abstract available


  6. BACHIR M, Allem R, Benejat L, Tifrit A, et al
    Molecular detection of mutations involved in Helicobacter pylori antibiotic resistance in Algeria.
    J Antimicrob Chemother. 2018 May 11. pii: 4995220. doi: 10.1093.
    PubMed     Text format     Abstract available


  7. NYGAARD JENSEN J, Melander E, Hedin K, Bjerrum L, et al
    Comparison of antibiotic prescribing and antimicrobial resistance in urinary tract infections at the municipal level among women in two Nordic regions.
    J Antimicrob Chemother. 2018 May 10. pii: 4995081. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2018
  8. GUPTA P, Mankere B, Chekkoora Keloth S, Tuteja U, et al
    Increased antibiotic resistance exhibited by the biofilm of Vibrio cholerae O139.
    J Antimicrob Chemother. 2018 Apr 24. pii: 4984488. doi: 10.1093.
    PubMed     Text format     Abstract available


  9. SIMNER PJ, Antar AAR, Hao S, Gurtowski J, et al
    Antibiotic pressure on the acquisition and loss of antibiotic resistance genes in Klebsiella pneumoniae.
    J Antimicrob Chemother. 2018 Apr 10. pii: 4966148. doi: 10.1093.
    PubMed     Text format     Abstract available


  10. NAGU TJ, Aboud S, Matee MI, Maeurer MJ, et al
    Effects of isoniazid resistance on TB treatment outcomes under programmatic conditions in a high-TB and -HIV setting: a prospective multicentre study-authors' response.
    J Antimicrob Chemother. 2018 Apr 4. pii: 4960907. doi: 10.1093.
    PubMed     Text format    


  11. ANTONELLI A, D'Andrea MM, Brenciani A, Galeotti CL, et al
    Characterization of poxtA, a novel phenicol-oxazolidinone-tetracycline resistance gene from an MRSA of clinical origin.
    J Antimicrob Chemother. 2018 Apr 4. pii: 4960904. doi: 10.1093.
    PubMed     Text format     Abstract available


  12. TORUMKUNEY D, Pertseva T, Bratus E, Dziublik A, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Ukraine and the Slovak Republic.
    J Antimicrob Chemother. 2018;73.
    PubMed     Text format     Abstract available


  13. TORUMKUNEY D, Papaparaskevas J, Morrissey I
    Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Greece.
    J Antimicrob Chemother. 2018;73.
    PubMed     Text format     Abstract available


  14. TORUMKUNEY D, Zemlickova H, Maruscak M, Morrissey I, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in the Czech Republic.
    J Antimicrob Chemother. 2018;73.
    PubMed     Text format     Abstract available


  15. TORUMKUNEY D, Nica M, Nistor I, Vatcheva-Dobrevska R, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Bulgaria, Romania, Serbia and Croatia.
    J Antimicrob Chemother. 2018;73.
    PubMed     Text format     Abstract available


  16. TORUMKUNEY D, Mayanskiy N, Edelstein M, Sidorenko S, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Russia.
    J Antimicrob Chemother. 2018;73.
    PubMed     Text format     Abstract available


    March 2018
  17. SCHNEIDER S, Salm F, Vincze S, Moeser A, et al
    Perceptions and attitudes regarding antibiotic resistance in Germany: a cross-sectoral survey amongst physicians, veterinarians, farmers and the general public.
    J Antimicrob Chemother. 2018 Mar 26. pii: 4953726. doi: 10.1093.
    PubMed     Text format     Abstract available


  18. WAREHAM DW, Phee LM, Abdul Momin MHF
    Direct detection of carbapenem resistance determinants in clinical specimens using immunochromatographic lateral flow devices.
    J Antimicrob Chemother. 2018 Mar 22. pii: 4951547. doi: 10.1093.
    PubMed     Text format    


  19. VAN HAL SJ, Beukers AG, Timms VJ, Ellem JA, et al
    Relentless spread and adaptation of non-typeable vanA vancomycin-resistant Enterococcus faecium: a genome-wide investigation.
    J Antimicrob Chemother. 2018 Mar 16. pii: 4939528. doi: 10.1093.
    PubMed     Text format     Abstract available


  20. PRICE L, Gozdzielewska L, Young M, Smith F, et al
    Effectiveness of interventions to improve the public's antimicrobial resistance awareness and behaviours associated with prudent use of antimicrobials: a systematic review.
    J Antimicrob Chemother. 2018 Mar 14. pii: 4937884. doi: 10.1093.
    PubMed     Text format     Abstract available


  21. ASHLEY EA, Recht J, Chua A, Dance D, et al
    An inventory of supranational antimicrobial resistance surveillance networks involving low- and middle-income countries since 2000.
    J Antimicrob Chemother. 2018 Mar 5. pii: 4921008. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2018
  22. ROHDE AM, Wiese-Posselt M, Zweigner J, Schwab F, et al
    High admission prevalence of fluoroquinolone resistance in third-generation cephalosporin-resistant Enterobacteriaceae in German university hospitals.
    J Antimicrob Chemother. 2018 Feb 27. pii: 4911557. doi: 10.1093.
    PubMed     Text format     Abstract available


  23. HEMARAJATA P, Amick T, Yang S, Gregson A, et al
    Selection of hyperproduction of AmpC and SME-1 in a carbapenem-resistant Serratia marcescens isolate during antibiotic therapy.
    J Antimicrob Chemother. 2018 Feb 19. pii: 4877955. doi: 10.1093.
    PubMed     Text format     Abstract available


  24. LEBRETON F, Valentino MD, Schaufler K, Earl AM, et al
    Transferable vancomycin resistance in clade B commensal-type Enterococcus faecium.
    J Antimicrob Chemother. 2018 Feb 14. pii: 4859672. doi: 10.1093.
    PubMed     Text format     Abstract available


  25. DAMIAO GOUVEIA AC, Unemo M, Jensen JS
    In vitro activity of zoliflodacin (ETX0914) against macrolide-resistant, fluoroquinolone-resistant and antimicrobial-susceptible Mycoplasma genitalium strains.
    J Antimicrob Chemother. 2018 Feb 12. pii: 4850948. doi: 10.1093.
    PubMed     Text format     Abstract available


    January 2018
  26. POUWELS KB, Freeman R, Muller-Pebody B, Rooney G, et al
    Association between use of different antibiotics and trimethoprim resistance: going beyond the obvious crude association.
    J Antimicrob Chemother. 2018 Jan 31. pii: 4832009. doi: 10.1093.
    PubMed     Text format     Abstract available


  27. BRYCE A, Costelloe C, Wootton M, Butler CC, et al
    Comparison of risk factors for, and prevalence of, antibiotic resistance in contaminating and pathogenic urinary Escherichia coli in children in primary care: prospective cohort study.
    J Antimicrob Chemother. 2018 Jan 29. pii: 4828185. doi: 10.1093.
    PubMed     Text format     Abstract available


  28. PARTRIDGE SR, Tsafnat G
    Automated annotation of mobile antibiotic resistance in Gram-negative bacteria: the Multiple Antibiotic Resistance Annotator (MARA) and database.
    J Antimicrob Chemother. 2018 Jan 23. pii: 4823430. doi: 10.1093.
    PubMed     Text format     Abstract available


  29. XIE M, Li R, Liu Z, Chan EWC, et al
    Recombination of plasmids in a carbapenem-resistant NDM-5-producing clinical Escherichia coli isolate.
    J Antimicrob Chemother. 2018 Jan 23. pii: 4823432. doi: 10.1093.
    PubMed     Text format     Abstract available


  30. ROZWANDOWICZ M, Brouwer MSM, Fischer J, Wagenaar JA, et al
    Plasmids carrying antimicrobial resistance genes in Enterobacteriaceae.
    J Antimicrob Chemother. 2018 Jan 23. pii: 4822282. doi: 10.1093.
    PubMed     Text format     Abstract available


  31. TEBANO G, la Martire G, Sarmento N, Francis JR, et al
    Antibiotic resistance in Timor-Leste: a systematic review of evidence.
    J Antimicrob Chemother. 2018 Jan 22. pii: 4819241. doi: 10.1093.
    PubMed     Text format    


  32. BASUINO L, Jousselin A, Alexander JAN, Strynadka NCJ, et al
    PBP4 activity and its overexpression are necessary for PBP4-mediated high-level beta-lactam resistance.
    J Antimicrob Chemother. 2018 Jan 19. pii: 4817624. doi: 10.1093.
    PubMed     Text format     Abstract available


  33. HAENSSGEN MJ, Charoenboon N, Khine Zaw Y
    It is time to give social research a voice to tackle antimicrobial resistance?
    J Antimicrob Chemother. 2018 Jan 18. pii: 4817296. doi: 10.1093.
    PubMed     Text format    


  34. SASSI M, Guerin F, Lesec L, Isnard C, et al
    Genetic characterization of a VanG-type vancomycin-resistant Enterococcus faecium clinical isolate.
    J Antimicrob Chemother. 2018 Jan 16. pii: 4812002. doi: 10.1093.
    PubMed     Text format     Abstract available


  35. REISSIER S, Saleh-Mghir A, Guerin F, Massias L, et al
    In vivo daptomycin efficacy against experimental vancomycin-resistant Enterococcus faecium endocarditis.
    J Antimicrob Chemother. 2018 Jan 9. pii: 4796903. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2017
  36. VAN DEN BUNT G, Top J, Hordijk J, de Greeff SC, et al
    Intestinal carriage of ampicillin- and vancomycin-resistant Enterococcus faecium in humans, dogs and cats in the Netherlands.
    J Antimicrob Chemother. 2017 Dec 25. pii: 4774625. doi: 10.1093.
    PubMed     Text format     Abstract available


  37. DECROO T, Van Deun A, Lynen L
    Comment on: Effects of isoniazid resistance on TB treatment outcomes under programmatic conditions in a high-TB and -HIV setting: a prospective multicentre study.
    J Antimicrob Chemother. 2017 Dec 25. pii: 4774628. doi: 10.1093.
    PubMed     Text format    


  38. KLOTZ P, Jacobmeyer L, Stamm I, Leidner U, et al
    Carbapenem-resistant Acinetobacter baumannii ST294 harbouring the OXA-72 carbapenemase from a captive grey parrot.
    J Antimicrob Chemother. 2017 Dec 21. pii: 4772354. doi: 10.1093.
    PubMed     Text format    


  39. BERGLUND B, Hoang NTB, Tarnberg M, Le NK, et al
    Colistin- and carbapenem-resistant Klebsiella pneumoniae carrying mcr-1 and blaOXA-48 isolated at a paediatric hospital in Vietnam.
    J Antimicrob Chemother. 2017 Dec 15. pii: 4748887. doi: 10.1093.
    PubMed     Text format    


  40. WOODFORD N, Xu-McCrae L, Mushtaq S, Wu HHT, et al
    Prevalence of carbapenem resistance and carbapenemase production among Enterobacteriaceae isolated from urine in the UK: results of the UK infection-Carbapenem Resistance Evaluation Surveillance Trial (iCREST-UK).
    J Antimicrob Chemother. 2017 Dec 15. pii: 4748884. doi: 10.1093.
    PubMed     Text format     Abstract available


  41. CASPAR Y, Hennebique A, Maurin M
    Antibiotic susceptibility of Francisella tularensis subsp. holarctica strains isolated from tularaemia patients in France between 2006 and 2016.
    J Antimicrob Chemother. 2017 Dec 14. pii: 4745834. doi: 10.1093.
    PubMed     Text format     Abstract available


  42. HARRIS PNA, Ben Zakour NL, Roberts LW, Wailan AM, et al
    Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27.
    J Antimicrob Chemother. 2017 Dec 14. pii: 4745835. doi: 10.1093.
    PubMed     Text format     Abstract available


  43. DAY MR, Doumith M, Do Nascimento V, Nair S, et al
    Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of Salmonella enterica serovars Typhi and Paratyphi.
    J Antimicrob Chemother. 2017 Dec 5. pii: 4693726. doi: 10.1093.
    PubMed     Text format     Abstract available


    November 2017
  44. HOMBACH M, Jetter M, Blochliger N, Kolesnik-Goldmann N, et al
    Rapid disc diffusion antibiotic susceptibility testing for Pseudomonas aeruginosa, Acinetobacter baumannii and Enterococcus spp.
    J Antimicrob Chemother. 2017 Nov 23. pii: 4654829. doi: 10.1093.
    PubMed     Text format     Abstract available


  45. FJALSTAD JW, Esaiassen E, Juvet LK, van den Anker JN, et al
    Antibiotic therapy in neonates and impact on gut microbiota and antibiotic resistance development: a systematic review.
    J Antimicrob Chemother. 2017 Nov 22. pii: 4652876. doi: 10.1093.
    PubMed     Text format     Abstract available


  46. LEE RS, Seemann T, Heffernan H, Kwong JC, et al
    Genomic epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in New Zealand.
    J Antimicrob Chemother. 2017 Nov 22. pii: 4647718. doi: 10.1093.
    PubMed     Text format     Abstract available


  47. CAI Y, Yang D, Wang J, Wang R, et al
    Activity of colistin alone or in combination with rifampicin or meropenem in a carbapenem-resistant bioluminescent Pseudomonas aeruginosa intraperitoneal murine infection model.
    J Antimicrob Chemother. 2017 Nov 14. doi: 10.1093.
    PubMed     Text format     Abstract available


  48. MARQUES C, Belas A, Franco A, Aboim C, et al
    Increase in antimicrobial resistance and emergence of major international high-risk clonal lineages in dogs and cats with urinary tract infection: 16 year retrospective study.
    J Antimicrob Chemother. 2017 Nov 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  49. KOSHKOLDA T, Luck C
    Antibiotic susceptibility of clinical Legionella pneumophila serogroup 1 strains isolated in Germany.
    J Antimicrob Chemother. 2017 Nov 9. doi: 10.1093.
    PubMed     Text format    


    October 2017
  50. HOLYK A, Belden V, Lee JJ, Musick W, et al
    Ceftazidime/avibactam use for carbapenem-resistant Klebsiella pneumoniae meningitis: a case report.
    J Antimicrob Chemother. 2017 Oct 10. doi: 10.1093.
    PubMed     Text format    


  51. JIMENEZ-CASTELLANOS JC, Wan Nur Ismah WAK, Takebayashi Y, Findlay J, et al
    Envelope proteome changes driven by RamA overproduction in Klebsiella pneumoniae that enhance acquired beta-lactam resistance.
    J Antimicrob Chemother. 2017 Oct 6. doi: 10.1093.
    PubMed     Text format     Abstract available


  52. MCDONNELL L, Armstrong D, Ashworth M, Dregan A, et al
    National disparities in the relationship between antimicrobial resistance and antimicrobial consumption in Europe: an observational study in 29 countries-authors' response.
    J Antimicrob Chemother. 2017 Oct 4. doi: 10.1093.
    PubMed     Text format    


  53. ZHANG Y, Kashikar A, Bush K
    In vitro activity of plazomicin against beta-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE).
    J Antimicrob Chemother. 2017;72:2792-2795.
    PubMed     Text format     Abstract available


  54. BRENNAN-KROHN T, Truelson KA, Smith KP, Kirby JE, et al
    Screening for synergistic activity of antimicrobial combinations against carbapenem-resistant Enterobacteriaceae using inkjet printer-based technology.
    J Antimicrob Chemother. 2017;72:2775-2781.
    PubMed     Text format     Abstract available


  55. ZANKARI E, Allesoe R, Joensen KG, Cavaco LM, et al
    PointFinder: a novel web tool for WGS-based detection of antimicrobial resistance associated with chromosomal point mutations in bacterial pathogens.
    J Antimicrob Chemother. 2017;72:2764-2768.
    PubMed     Text format     Abstract available


  56. OVIANO M, Gomara M, Barba MJ, Sparbier K, et al
    Quantitative and automated MALDI-TOF MS-based detection of the plasmid-mediated quinolone resistance determinant AAC(6')-Ib-cr in Enterobacteriaceae.
    J Antimicrob Chemother. 2017;72:2952-2954.
    PubMed     Text format    


  57. LEE MC, Sun PL, Wu TL, Wang LH, et al
    Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan.
    J Antimicrob Chemother. 2017;72:2782-2786.
    PubMed     Text format     Abstract available


  58. DOUMITH M, Mushtaq S, Martin V, Chaudhry A, et al
    Genomic sequences of Streptococcus agalactiae with high-level gentamicin resistance, collected in the BSAC bacteraemia surveillance.
    J Antimicrob Chemother. 2017;72:2704-2707.
    PubMed     Text format     Abstract available


  59. WEBBER MA, Buckner MMC, Redgrave LS, Ifill G, et al
    Quinolone-resistant gyrase mutants demonstrate decreased susceptibility to triclosan.
    J Antimicrob Chemother. 2017;72:2755-2763.
    PubMed     Text format     Abstract available


  60. SCORNEC H, Bellanger X, Guilloteau H, Groshenry G, et al
    Inducibility of Tn916 conjugative transfer in Enterococcus faecalis by subinhibitory concentrations of ribosome-targeting antibiotics.
    J Antimicrob Chemother. 2017;72:2722-2728.
    PubMed     Text format     Abstract available


    September 2017
  61. ARANA DM, Ortega A, Gonzalez-Barbera E, Lara N, et al
    Carbapenem-resistant Citrobacter spp. isolated in Spain from 2013 to 2015 produced a variety of carbapenemases including VIM-1, OXA-48, KPC-2, NDM-1 and VIM-2.
    J Antimicrob Chemother. 2017 Sep 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  62. ZHANG Q, Hua X, Ruan Z, Yu Y, et al
    Revisiting the contribution of gene duplication of blaOXA-23 in carbapenem-resistant Acinetobacter baumannii.
    J Antimicrob Chemother. 2017 Sep 27. doi: 10.1093.
    PubMed     Text format    


  63. PULCINI C
    Comment on: National disparities in the relationship between antimicrobial resistance and antimicrobial consumption in Europe: an observational study in 29 countries.
    J Antimicrob Chemother. 2017 Sep 18. doi: 10.1093.
    PubMed     Text format    


  64. DO NASCIMENTO V, Day MR, Doumith M, Hopkins KL, et al
    Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of enteroaggregative Escherichia coli isolated from cases of diarrhoeal disease in England, 2015-16.
    J Antimicrob Chemother. 2017 Sep 11. doi: 10.1093.
    PubMed     Text format     Abstract available


  65. WU CJ, Lai JF, Huang IW, Hsieh LY, et al
    Multiclonal emergence of levofloxacin-resistant group B Streptococcus, Taiwan.
    J Antimicrob Chemother. 2017 Sep 6. doi: 10.1093.
    PubMed     Text format     Abstract available


  66. SRIVASTAVA S, Deshpande D, Gumbo T
    Failure of the azithromycin and ethambutol combination regimen in the hollow-fibre system model of pulmonary Mycobacterium avium infection is due to acquired resistance.
    J Antimicrob Chemother. 2017;72.
    PubMed     Text format     Abstract available


  67. LEE GC, Dallas SD, Wang Y, Olsen RJ, et al
    Emerging multidrug resistance in community-associated Staphylococcus aureus involved in skin and soft tissue infections and nasal colonization.
    J Antimicrob Chemother. 2017;72:2461-2468.
    PubMed     Text format     Abstract available


    August 2017
  68. LAZARIS A, Coleman DC, Kearns AM, Pichon B, et al
    Novel multiresistance cfr plasmids in linezolid-resistant methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium (VRE) from a hospital outbreak: co-location of cfr and optrA in VRE.
    J Antimicrob Chemother. 2017 Aug 28. doi: 10.1093.
    PubMed     Text format     Abstract available


  69. CHANG SC, Lee MH, Yeh CF, Liu TP, et al
    Characterization of two novel variants of staphylococcal cassette chromosome mec elements in oxacillin-resistant Staphylococcus lugdunensis.
    J Antimicrob Chemother. 2017 Aug 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  70. ATKINSON CT, Kunde DA, Tristram SG
    Expression of acquired macrolide resistance genes in Haemophilus influenzae.
    J Antimicrob Chemother. 2017 Aug 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  71. PRASKI ALZRIGAT L, Huseby DL, Brandis G, Hughes D, et al
    Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli.
    J Antimicrob Chemother. 2017 Aug 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  72. NIGRO SJ, Hall RM
    A large plasmid, pD46-4, carrying a complex resistance region in an extensively antibiotic-resistant ST25 Acinetobacter baumannii.
    J Antimicrob Chemother. 2017 Aug 14. doi: 10.1093.
    PubMed     Text format    


  73. HOMBACH M, Jetter M, Keller PM, Blochliger N, et al
    Rapid detection of ESBL, carbapenemases, MRSA and other important resistance phenotypes within 6-8 h by automated disc diffusion antibiotic susceptibility testing.
    J Antimicrob Chemother. 2017 Aug 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  74. SCHAUWVLIEGHE AFAD, Vonk AG, Buddingh EP, Hoek RAS, et al
    Detection of azole-susceptible and azole-resistant Aspergillus coinfection by cyp51A PCR amplicon melting curve analysis.
    J Antimicrob Chemother. 2017 Aug 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  75. ZELLWEGER RM, Carrique-Mas J, Limmathurotsakul D, Day NPJ, et al
    A current perspective on antimicrobial resistance in Southeast Asia.
    J Antimicrob Chemother. 2017 Aug 7. doi: 10.1093.
    PubMed     Text format     Abstract available


  76. WEBER RE, Layer F, Klare I, Werner G, et al
    Comparative evaluation of VITEK(R) 2 and three commercial gradient strip assays for daptomycin susceptibility testing of Staphylococcus aureus.
    J Antimicrob Chemother. 2017 Aug 7. doi: 10.1093.
    PubMed     Text format     Abstract available


  77. SMITH NM, Bulman ZP, Sieron AO, Bulitta JB, et al
    Pharmacodynamics of dose-escalated 'front-loading' polymyxin B regimens against polymyxin-resistant mcr-1-harbouring Escherichia coli.
    J Antimicrob Chemother. 2017;72:2297-2303.
    PubMed     Text format     Abstract available


  78. ROMINSKI A, Selchow P, Becker K, Brulle JK, et al
    Elucidation of Mycobacterium abscessus aminoglycoside and capreomycin resistance by targeted deletion of three putative resistance genes.
    J Antimicrob Chemother. 2017;72:2191-2200.
    PubMed     Text format     Abstract available


  79. BRENNER BG, Ibanescu RI, Oliveira M, Roger M, et al
    HIV-1 strains belonging to large phylogenetic clusters show accelerated escape from integrase inhibitors in cell culture compared with viral isolates from singleton/small clusters.
    J Antimicrob Chemother. 2017;72:2171-2183.
    PubMed     Text format     Abstract available


  80. SOULIE C, Grude M, Descamps D, Amiel C, et al
    Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma.
    J Antimicrob Chemother. 2017;72:2351-2354.
    PubMed     Text format     Abstract available


  81. OVIANO M, Gomara M, Barba MJ, Revillo MJ, et al
    Towards the early detection of beta-lactamase-producing Enterobacteriaceae by MALDI-TOF MS analysis.
    J Antimicrob Chemother. 2017;72:2259-2262.
    PubMed     Text format     Abstract available


    July 2017
  82. FIRSOV AA, Alieva KN, Strukova EN, Golikova MV, et al
    Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to linezolid in an in vitro dynamic model.
    J Antimicrob Chemother. 2017 Jul 31. doi: 10.1093.
    PubMed     Text format     Abstract available


  83. MCDONNELL L, Armstrong D, Ashworth M, Dregan A, et al
    National disparities in the relationship between antimicrobial resistance and antimicrobial consumption in Europe: an observational study in 29 countries.
    J Antimicrob Chemother. 2017 Jul 25. doi: 10.1093.
    PubMed     Text format     Abstract available


  84. KWON HI, Kim S, Oh MH, Na SH, et al
    Outer membrane protein A contributes to antimicrobial resistance of Acinetobacter baumannii through the OmpA-like domain.
    J Antimicrob Chemother. 2017 Jul 24. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2017
  85. HAMIDIAN M, Hall RM
    Origin of the AbGRI1 antibiotic resistance island found in the comM gene of Acinetobacter baumannii GC2 isolates.
    J Antimicrob Chemother. 2017 Jun 28. doi: 10.1093.
    PubMed     Text format    


  86. DI SANTE L, Morroni G, Brenciani A, Vignaroli C, et al
    pHTbeta-promoted mobilization of non-conjugative resistance plasmids from Enterococcus faecium to Enterococcus faecalis.
    J Antimicrob Chemother. 2017 Jun 22. doi: 10.1093.
    PubMed     Text format     Abstract available


  87. VOURLI S, Dafopoulou K, Vrioni G, Tsakris A, et al
    Evaluation of two automated systems for colistin susceptibility testing of carbapenem-resistant Acinetobacter baumannii clinical isolates.
    J Antimicrob Chemother. 2017 Jun 12. doi: 10.1093.
    PubMed     Text format     Abstract available


  88. TOMASO H, Hotzel H, Otto P, Myrtennas K, et al
    Antibiotic susceptibility in vitro of Francisella tularensis subsp. holarctica isolates from Germany.
    J Antimicrob Chemother. 2017 Jun 12. doi: 10.1093.
    PubMed     Text format     Abstract available


  89. BUIL JB, Rijs AJMM, Meis JF, Birch M, et al
    In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates.
    J Antimicrob Chemother. 2017 Jun 10. doi: 10.1093.
    PubMed     Text format     Abstract available


  90. POWELL N, Davidson I, Yelling P, Collinson A, et al
    Developing a local antimicrobial resistance action plan: the Cornwall One Health Antimicrobial Resistance Group.
    J Antimicrob Chemother. 2017 Jun 7. doi: 10.1093.
    PubMed     Text format     Abstract available


  91. SADOUKI Z, Day MR, Doumith M, Chattaway MA, et al
    Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of Shigella sonnei isolated from cases of diarrhoeal disease in England and Wales, 2015.
    J Antimicrob Chemother. 2017 Jun 7. doi: 10.1093.
    PubMed     Text format     Abstract available


  92. STANCZAK-MROZEK KI, Laing KG, Lindsay JA
    Resistance gene transfer: induction of transducing phage by sub-inhibitory concentrations of antimicrobials is not correlated to induction of lytic phage.
    J Antimicrob Chemother. 2017;72:1624-1631.
    PubMed     Text format     Abstract available


  93. MUSICHA P, Feasey NA, Cain AK, Kallonen T, et al
    Genomic landscape of extended-spectrum beta-lactamase resistance in Escherichia coli from an urban African setting.
    J Antimicrob Chemother. 2017;72:1602-1609.
    PubMed     Text format     Abstract available


  94. MUSHTAQ S, Vickers A, Woodford N, Livermore DM, et al
    WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D beta-lactamases.
    J Antimicrob Chemother. 2017;72:1688-1695.
    PubMed     Text format     Abstract available


  95. ANDRADE SD, Sabido M, Monteiro WM, Benzaken AS, et al
    Drug resistance in antiretroviral-naive children newly diagnosed with HIV-1 in Manaus, Amazonas.
    J Antimicrob Chemother. 2017;72:1774-1783.
    PubMed     Text format     Abstract available


  96. HOBBS MR, Grant CC, Ritchie SR, Chelimo C, et al
    Antibiotic consumption by New Zealand children: exposure is near universal by the age of 5 years.
    J Antimicrob Chemother. 2017;72:1832-1840.
    PubMed     Text format     Abstract available


  97. BRETAGNE S, Renaudat C, Desnos-Ollivier M, Sitbon K, et al
    Predisposing factors and outcome of uncommon yeast species-related fungaemia based on an exhaustive surveillance programme (2002-14).
    J Antimicrob Chemother. 2017;72:1784-1793.
    PubMed     Text format     Abstract available


  98. ASSOUMOU L, Charpentier C, Recordon-Pinson P, Grude M, et al
    Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide study.
    J Antimicrob Chemother. 2017;72:1769-1773.
    PubMed     Text format     Abstract available


  99. ZHOU YF, Tao MT, Feng Y, Yang RS, et al
    Increased activity of colistin in combination with amikacin against Escherichia coli co-producing NDM-5 and MCR-1.
    J Antimicrob Chemother. 2017;72:1723-1730.
    PubMed     Text format     Abstract available


  100. NISHIKAWA H, Fukuda Y, Mitsuyama J, Tashiro M, et al
    In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen.
    J Antimicrob Chemother. 2017;72:1709-1713.
    PubMed     Text format     Abstract available


  101. TANG Y, Dai L, Sahin O, Wu Z, et al
    Emergence of a plasmid-borne multidrug resistance gene cfr(C) in foodborne pathogen Campylobacter.
    J Antimicrob Chemother. 2017;72:1581-1588.
    PubMed     Text format     Abstract available


  102. KAUSHIK A, Ammerman NC, Tasneen R, Story-Roller E, et al
    In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2017 Jun 1. doi: 10.1093.
    PubMed     Text format     Abstract available


  103. HURST SF, Berkow EL, Stevenson KL, Litvintseva AP, et al
    Isolation of azole-resistant Aspergillus fumigatus from the environment in the south-eastern USA.
    J Antimicrob Chemother. 2017 Jun 1. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2017
  104. ALAUZET C, Berger S, Jean-Pierre H, Dubreuil L, et al
    nimH, a novel nitroimidazole resistance gene contributing to metronidazole resistance in Bacteroides fragilis.
    J Antimicrob Chemother. 2017 May 23. doi: 10.1093.
    PubMed     Text format    


  105. SHU JC, Kuo AJ, Su LH, Liu TP, et al
    Development of carbapenem resistance in Pseudomonas aeruginosa is associated with OprD polymorphisms, particularly the amino acid substitution at codon 170.
    J Antimicrob Chemother. 2017 May 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  106. AMBROSIONI J, Mosquera MM, Miro JM
    Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection-authors' response.
    J Antimicrob Chemother. 2017;72:1547-1548.
    PubMed     Text format    


  107. FABRIZIO C, Lepore L, Lagioia A, Punzi G, et al
    Comment on: Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection.
    J Antimicrob Chemother. 2017;72:1546-1547.
    PubMed     Text format    


  108. PFALLER MA, Bassetti M, Duncan LR, Castanheira M, et al
    Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012-15).
    J Antimicrob Chemother. 2017;72:1386-1395.
    PubMed     Text format     Abstract available


  109. GOODALL RL, Dunn DT, Nkurunziza P, Mugarura L, et al
    Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan Africa.
    J Antimicrob Chemother. 2017;72:1450-1455.
    PubMed     Text format     Abstract available


  110. TAM VH, Chang KT, Zhou J, Ledesma KR, et al
    Determining beta-lactam exposure threshold to suppress resistance development in Gram-negative bacteria.
    J Antimicrob Chemother. 2017;72:1421-1428.
    PubMed     Text format     Abstract available


  111. GUENTHER S, Falgenhauer L, Semmler T, Imirzalioglu C, et al
    Environmental emission of multiresistant Escherichia coli carrying the colistin resistance gene mcr-1 from German swine farms.
    J Antimicrob Chemother. 2017;72:1289-1292.
    PubMed     Text format     Abstract available


  112. DUPRILOT M, Decre D, Genel N, Drieux L, et al
    Diversity and functionality of plasmid-borne VagCD toxin-antitoxin systems of Klebsiella pneumoniae.
    J Antimicrob Chemother. 2017;72:1320-1326.
    PubMed     Text format     Abstract available


  113. ROUKENS M, Verhoef L, Stobberingh E, Natsch S, et al
    Surveillance of antimicrobial use in Dutch long-term care facilities.
    J Antimicrob Chemother. 2017;72:1516-1520.
    PubMed     Text format     Abstract available


  114. BALLESTERO-TELLEZ M, Docobo-Perez F, Portillo-Calderon I, Rodriguez-Martinez JM, et al
    Molecular insights into fosfomycin resistance in Escherichia coli.
    J Antimicrob Chemother. 2017;72:1303-1309.
    PubMed     Text format     Abstract available


  115. LANGE F, Pfennigwerth N, Gerigk S, Gohlke F, et al
    Dissemination of blaOXA-58 in Proteus mirabilis isolates from Germany.
    J Antimicrob Chemother. 2017;72:1334-1339.
    PubMed     Text format     Abstract available


  116. VAN EIJK E, Wittekoek B, Kuijper EJ, Smits WK, et al
    DNA replication proteins as potential targets for antimicrobials in drug-resistant bacterial pathogens.
    J Antimicrob Chemother. 2017;72:1275-1284.
    PubMed     Text format     Abstract available


    April 2017
  117. EHRMANN E, Jolivet-Gougeon A, Bonnaure-Mallet M, Fosse T, et al
    Role of DNA gyrase and topoisomerase IV mutations in fluoroquinolone resistance of Capnocytophaga spp. clinical isolates and laboratory mutants.
    J Antimicrob Chemother. 2017 Apr 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  118. ZIMENKOV DV, Nosova EY, Kulagina EV, Antonova OV, et al
    Examination of bedaquiline- and linezolid-resistant Mycobacterium tuberculosis isolates from the Moscow region.
    J Antimicrob Chemother. 2017 Apr 6. doi: 10.1093.
    PubMed     Text format     Abstract available


  119. OVEJERO CM, Delgado-Blas JF, Calero-Caceres W, Muniesa M, et al
    Spread of mcr-1-carrying Enterobacteriaceae in sewage water from Spain.
    J Antimicrob Chemother. 2017;72:1050-1053.
    PubMed     Text format     Abstract available


  120. PFENNIGWERTH N, Lange F, Belmar Campos C, Hentschke M, et al
    Genetic and biochemical characterization of HMB-1, a novel subclass B1 metallo-beta-lactamase found in a Pseudomonas aeruginosa clinical isolate.
    J Antimicrob Chemother. 2017;72:1068-1073.
    PubMed     Text format     Abstract available


  121. CROSS EL, Tolfree R, Kipping R
    Systematic review of public-targeted communication interventions to improve antibiotic use.
    J Antimicrob Chemother. 2017;72:975-987.
    PubMed     Text format     Abstract available


  122. WATTAL C, Chakrabarti A, Oberoi JK, Donnelly JP, et al
    Issues in antifungal stewardship: an opportunity that should not be lost.
    J Antimicrob Chemother. 2017;72:969-974.
    PubMed     Text format     Abstract available


  123. JOHNSON AP, Muller-Pebody B, Budd E, Ashiru-Oredope D, et al
    Improving feedback of surveillance data on antimicrobial consumption, resistance and stewardship in England: putting the data at your Fingertips.
    J Antimicrob Chemother. 2017;72:953-956.
    PubMed     Text format     Abstract available


  124. CHAPMAN B, Slavin M, Marriott D, Halliday C, et al
    Changing epidemiology of candidaemia in Australia.
    J Antimicrob Chemother. 2017;72:1103-1108.
    PubMed     Text format     Abstract available


  125. MADELAIN V, Le MP, Champenois K, Charpentier C, et al
    Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case-control study.
    J Antimicrob Chemother. 2017;72:1137-1146.
    PubMed     Text format     Abstract available


  126. SOUSA DOMINGUEZ A, Perez-Rodriguez MT, Nodar A, Martinez-Lamas L, et al
    Successful treatment of MDR Pseudomonas aeruginosa skin and soft-tissue infection with ceftolozane/tazobactam.
    J Antimicrob Chemother. 2017;72:1262-1263.
    PubMed     Text format    


    March 2017
  127. SAN-JUAN R, Fernandez-Ruiz M, Gasch O, Camoez M, et al
    High vancomycin MICs predict the development of infective endocarditis in patients with catheter-related bacteraemia due to methicillin-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 2017 Mar 31. doi: 10.1093.
    PubMed     Text format     Abstract available


  128. FALAGAS ME, Skalidis T, Vardakas KZ, Legakis NJ, et al
    Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals.
    J Antimicrob Chemother. 2017 Mar 22. doi: 10.1093.
    PubMed     Text format     Abstract available


  129. ROER L, Hansen F, Thomsen MC, Knudsen JD, et al
    WGS-based surveillance of third-generation cephalosporin-resistant Escherichia coli from bloodstream infections in Denmark.
    J Antimicrob Chemother. 2017 Mar 22. doi: 10.1093.
    PubMed     Text format     Abstract available


  130. HAMIDIAN M, Nigro SJ, Hartstein RM, Hall RM, et al
    RCH51, a multiply antibiotic-resistant Acinetobacter baumannii ST103IP isolate, carries resistance genes in three plasmids, including a novel potentially conjugative plasmid carrying oxa235 in transposon Tn6252.
    J Antimicrob Chemother. 2017 Mar 13. doi: 10.1093.
    PubMed     Text format     Abstract available


  131. HAWKINS PA, Law CS, Metcalf BJ, Chochua S, et al
    Cross-resistance to lincosamides, streptogramins A and pleuromutilins in Streptococcus agalactiae isolates from the USA.
    J Antimicrob Chemother. 2017 Mar 13. doi: 10.1093.
    PubMed     Text format     Abstract available


  132. JAGANATH D, Schaaf HS, Donald PR
    Revisiting the mutant prevention concentration to guide dosing in childhood tuberculosis.
    J Antimicrob Chemother. 2017 Mar 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  133. GRONTHAL T, Eklund M, Thomson K, Piiparinen H, et al
    Antimicrobial resistance in Staphylococcus pseudintermedius and the molecular epidemiology of methicillin-resistant S. pseudintermedius in small animals in Finland.
    J Antimicrob Chemother. 2017 Mar 8. doi: 10.1093.
    PubMed     Text format    


  134. DE LASTOURS V, Maugy E, Mathy V, Chau F, et al
    Ecological impact of ciprofloxacin on commensal enterococci in healthy volunteers.
    J Antimicrob Chemother. 2017 Mar 4. doi: 10.1093.
    PubMed     Text format     Abstract available


  135. LASS-FLORL C, Cuenca-Estrella M
    Changes in the epidemiological landscape of invasive mould infections and disease.
    J Antimicrob Chemother. 2017;72.
    PubMed     Text format     Abstract available


  136. STEFIC K, Salmona M, Capitao M, Splittgerber M, et al
    Unravelling the dynamics of selection of multiresistant variants to integrase inhibitors in an HIV-1-infected child using ultra-deep sequencing.
    J Antimicrob Chemother. 2017;72:850-854.
    PubMed     Text format     Abstract available


  137. SULLY EK, Geller BL, Li L, Moody CM, et al
    Peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO) restores carbapenem susceptibility to NDM-1-positive pathogens in vitro and in vivo.
    J Antimicrob Chemother. 2017;72:782-790.
    PubMed     Text format     Abstract available


  138. KLETENKOV K, Hoffmann D, Boni J, Yerly S, et al
    Role of Gag mutations in PI resistance in the Swiss HIV cohort study: bystanders or contributors?
    J Antimicrob Chemother. 2017;72:866-875.
    PubMed     Text format     Abstract available


  139. DUGGETT NA, Sayers E, AbuOun M, Ellis RJ, et al
    Occurrence and characterization of mcr-1-harbouring Escherichia coli isolated from pigs in Great Britain from 2013 to 2015.
    J Antimicrob Chemother. 2017;72:691-695.
    PubMed     Text format     Abstract available


  140. BRIAND C, Dollfus C, Faye A, Kantor E, et al
    Efficacy and tolerance of dolutegravir-based combined ART in perinatally HIV-1-infected adolescents: a French multicentre retrospective study.
    J Antimicrob Chemother. 2017;72:837-843.
    PubMed     Text format     Abstract available


    February 2017
  141. LENHARD JR, Thamlikitkul V, Silveira FP, Garonzik SM, et al
    Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.
    J Antimicrob Chemother. 2017 Feb 28. doi: 10.1093.
    PubMed     Text format     Abstract available


  142. MOUGARI F, Loiseau J, Veziris N, Bernard C, et al
    Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.
    J Antimicrob Chemother. 2017 Feb 28. doi: 10.1093.
    PubMed     Text format     Abstract available


  143. CAVANAUGH JS, Jou R, Wu MH, Dalton T, et al
    Susceptibilities of MDR Mycobacterium tuberculosis isolates to unconventional drugs compared with their reported pharmacokinetic/pharmacodynamic parameters.
    J Antimicrob Chemother. 2017 Feb 20. doi: 10.1093.
    PubMed     Text format     Abstract available


  144. HOMBACH M, Jetter M, Blochliger N, Kolesnik-Goldmann N, et al
    Fully automated disc diffusion for rapid antibiotic susceptibility test results: a proof-of-principle study.
    J Antimicrob Chemother. 2017 Feb 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  145. PERICAS JM, Garcia-de-la-Maria C, Brunet M, Armero Y, et al
    Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.
    J Antimicrob Chemother. 2017 Feb 14. doi: 10.1093.
    PubMed     Text format    


  146. ROWE WP, Baker-Austin C, Verner-Jeffreys DW, Ryan JJ, et al
    Overexpression of antibiotic resistance genes in hospital effluents over time.
    J Antimicrob Chemother. 2017 Feb 8. doi: 10.1093.
    PubMed     Text format    


  147. WANG J, Guo ZW, Zhi CP, Yang T, et al
    Impact of plasmid-borne oqxAB on the development of fluoroquinolone resistance and bacterial fitness in Escherichia coli.
    J Antimicrob Chemother. 2017 Feb 4. doi: 10.1093.
    PubMed     Text format    


  148. BRAAM JF, Slotboom B, Van Marm S, Severs TT, et al
    High prevalence of the A2058T macrolide resistance-associated mutation in Mycoplasma genitalium strains from the Netherlands.
    J Antimicrob Chemother. 2017 Feb 3. doi: 10.1093.
    PubMed     Text format    


  149. BOIKOV DA, Locke JB, James KD, Bartizal K, et al
    In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis.
    J Antimicrob Chemother. 2017 Feb 3. doi: 10.1093.
    PubMed     Text format    


  150. MUNK P, Andersen VD, de Knegt L, Jensen MS, et al
    A sampling and metagenomic sequencing-based methodology for monitoring antimicrobial resistance in swine herds.
    J Antimicrob Chemother. 2017;72:385-392.
    PubMed     Text format     Abstract available


  151. LI R, Xie M, Zhang J, Yang Z, et al
    Genetic characterization of mcr-1-bearing plasmids to depict molecular mechanisms underlying dissemination of the colistin resistance determinant.
    J Antimicrob Chemother. 2017;72:393-401.
    PubMed     Text format     Abstract available


  152. BOERMA RS, Sigaloff KC, Akanmu AS, Inzaule S, et al
    Alarming increase in pretreatment HIV drug resistance in children living in sub-Saharan Africa: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2017;72:365-371.
    PubMed     Text format     Abstract available


  153. ZAHEDI BIALVAEI A, Rahbar M, Yousefi M, Asgharzadeh M, et al
    Linezolid: a promising option in the treatment of Gram-positives.
    J Antimicrob Chemother. 2017;72:354-364.
    PubMed     Text format     Abstract available


  154. ROMINSKI A, Roditscheff A, Selchow P, Bottger EC, et al
    Intrinsic rifamycin resistance of Mycobacterium abscessus is mediated by ADP-ribosyltransferase MAB_0591.
    J Antimicrob Chemother. 2017;72:376-384.
    PubMed     Text format     Abstract available


  155. BEYROUTHY R, Robin F, Hamze M, Bonnet R, et al
    IncFIIk plasmid harbouring an amplification of 16S rRNA methyltransferase-encoding gene rmtH associated with mobile element ISCR2.
    J Antimicrob Chemother. 2017;72:402-406.
    PubMed     Text format     Abstract available


  156. PADGET M, Tamarelle J, Herindrainy P, Ndir A, et al
    A community survey of antibiotic consumption among children in Madagascar and Senegal: the importance of healthcare access and care quality.
    J Antimicrob Chemother. 2017;72:564-573.
    PubMed     Text format     Abstract available


  157. GONZALEZ-SERNA A, Glas AC, Brumme CJ, Poon AF, et al
    Genotypic susceptibility score (GSS) and CD4+ T cell recovery in HIV-1 patients with suppressed viral load.
    J Antimicrob Chemother. 2017;72:496-503.
    PubMed     Text format     Abstract available


  158. TAN C, Vermeulen M, Wang X, Zvonar R, et al
    Variability in antibiotic use across Ontario acute care hospitals.
    J Antimicrob Chemother. 2017;72:554-563.
    PubMed     Text format     Abstract available


  159. BAILEY C, Tully MP, Pampaka M, Cooke J, et al
    Rasch analysis of the Antimicrobial Self-Assessment Toolkit for National Health Service (NHS) Trusts (ASAT v17).
    J Antimicrob Chemother. 2017;72:604-613.
    PubMed     Text format     Abstract available


  160. NY S, Lofmark S, Borjesson S, Englund S, et al
    Community carriage of ESBL-producing Escherichia coli is associated with strains of low pathogenicity: a Swedish nationwide study.
    J Antimicrob Chemother. 2017;72:582-588.
    PubMed     Text format     Abstract available


  161. BISSIO E, Barbas MG, Bouzas MB, Cudola A, et al
    Pretreatment HIV-1 drug resistance in Argentina: results from a surveillance study performed according to WHO-proposed new methodology in 2014-15.
    J Antimicrob Chemother. 2017;72:504-510.
    PubMed     Text format     Abstract available


  162. SADAHIRA T, Wada K, Araki M, Ishii A, et al
    Efficacy and safety of 3 day versus 7 day cefditoren pivoxil regimens for acute uncomplicated cystitis: multicentre, randomized, open-label trial.
    J Antimicrob Chemother. 2017;72:529-534.
    PubMed     Text format     Abstract available


  163. TREPANIER P, Mallard K, Meunier D, Pike R, et al
    Carbapenemase-producing Enterobacteriaceae in the UK: a national study (EuSCAPE-UK) on prevalence, incidence, laboratory detection methods and infection control measures.
    J Antimicrob Chemother. 2017;72:596-603.
    PubMed     Text format     Abstract available


  164. CABELLO FC, Godfrey HP
    Comment on: Transferable resistance to colistin: a new but old threat.
    J Antimicrob Chemother. 2017;72:636-637.
    PubMed     Text format    


    January 2017
  165. SUGIANLI AK, Ginting F, Kusumawati RL, Pranggono EH, et al
    Antimicrobial resistance in uropathogens and appropriateness of empirical treatment: a population-based surveillance study in Indonesia.
    J Antimicrob Chemother. 2017 Jan 30. pii: dkw578. doi: 10.1093.
    PubMed     Text format     Abstract available


  166. MASSIP C, Descours G, Ginevra C, Doublet P, et al
    Macrolide resistance in Legionella pneumophila: the role of LpeAB efflux pump.
    J Antimicrob Chemother. 2017 Jan 30. pii: dkw594. doi: 10.1093.
    PubMed     Text format     Abstract available


  167. TSANG RS, Shuel M, Whyte K, Hoang L, et al
    Antibiotic susceptibility and molecular analysis of invasive Haemophilus influenzae in Canada, 2007 to 2014.
    J Antimicrob Chemother. 2017 Jan 30. pii: dkw565. doi: 10.1093.
    PubMed     Text format     Abstract available


  168. LEDDA A, Price JR, Cole K, Llewelyn MJ, et al
    Re-emergence of methicillin susceptibility in a resistant lineage of Staphylococcus aureus.
    J Antimicrob Chemother. 2017 Jan 20. pii: dkw570. doi: 10.1093.
    PubMed     Text format     Abstract available


  169. MISCHNIK A, Baumert P, Hamprecht A, Rohde AM, et al
    In vitro susceptibility to 19 agents other than beta-lactams among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission.
    J Antimicrob Chemother. 2017 Jan 19. pii: dkw577. doi: 10.1093.
    PubMed     Text format     Abstract available


  170. STONE GG, Bradford PA, Yates K, Newell P, et al
    In vitro activity of ceftazidime/avibactam against urinary isolates from patients in a Phase 3 clinical trial programme for the treatment of complicated urinary tract infections.
    J Antimicrob Chemother. 2017 Jan 14. pii: dkw561. doi: 10.1093.
    PubMed     Text format     Abstract available


  171. MATSUMURA Y, Noguchi T, Tanaka M, Kanahashi T, et al
    Population structure of Japanese extraintestinal pathogenic Escherichia coli and its relationship with antimicrobial resistance.
    J Antimicrob Chemother. 2017 Jan 10. pii: dkw530. doi: 10.1093.
    PubMed     Text format     Abstract available


  172. SY SK, Zhuang L, Beaudoin ME, Kircher P, et al
    Potentiation of ceftazidime by avibactam against beta-lactam-resistant Pseudomonas aeruginosa in an in vitro infection model.
    J Antimicrob Chemother. 2017 Jan 10. pii: dkw535. doi: 10.1093.
    PubMed     Text format     Abstract available


  173. ROSELLO A, Hayward AC, Hopkins S, Horner C, et al
    Impact of long-term care facility residence on the antibiotic resistance of urinary tract Escherichia coli and Klebsiella.
    J Antimicrob Chemother. 2017 Jan 10. pii: dkw555. doi: 10.1093.
    PubMed     Text format     Abstract available


  174. BLACKWELL GA, Holt KE, Bentley SD, Hsu LY, et al
    Variants of AbGRI3 carrying the armA gene in extensively antibiotic-resistant Acinetobacter baumannii from Singapore.
    J Antimicrob Chemother. 2017 Jan 10. pii: dkw542. doi: 10.1093.
    PubMed     Text format     Abstract available


  175. GRONTHAL T, Eklund M, Thomson K, Piiparinen H, et al
    Antimicrobial resistance in Staphylococcus pseudintermedius and the molecular epidemiology of methicillin-resistant S. pseudintermedius in small animals in Finland.
    J Antimicrob Chemother. 2017 Jan 8. pii: dkw559. doi: 10.1093.
    PubMed     Text format     Abstract available


  176. OVIANO M, Rodriguez-Martinez JM, Pascual A, Bou G, et al
    Rapid detection of the plasmid-mediated quinolone resistance determinant AAC(6')-Ib-cr in Enterobacteriaceae by MALDI-TOF MS analysis.
    J Antimicrob Chemother. 2017 Jan 8. pii: dkw552. doi: 10.1093.
    PubMed     Text format     Abstract available


  177. XISTO MI, Caramalho RD, Rocha DA, Ferreira-Pereira A, et al
    Pan-azole-resistant Candida tropicalis carrying homozygous erg11 mutations at position K143R: a new emerging superbug?
    J Antimicrob Chemother. 2017 Jan 8. pii: dkw558. doi: 10.1093.
    PubMed     Text format     Abstract available


  178. OTSUKA T, Brauer AL, Kirkham C, Sully EK, et al
    Antimicrobial activity of antisense peptide-peptide nucleic acid conjugates against non-typeable Haemophilus influenzae in planktonic and biofilm forms.
    J Antimicrob Chemother. 2017;72:137-144.
    PubMed     Text format     Abstract available


  179. CUNNINGHAM E, Chan YT, Aghaizu A, Bibby DF, et al
    Enhanced surveillance of HIV-1 drug resistance in recently infected MSM in the UK.
    J Antimicrob Chemother. 2017;72:227-234.
    PubMed     Text format     Abstract available


  180. DEGHMANE AE, Hong E, Taha MK
    Emergence of meningococci with reduced susceptibility to third-generation cephalosporins.
    J Antimicrob Chemother. 2017;72:95-98.
    PubMed     Text format     Abstract available


  181. STEEGEN K, Bronze M, Papathanasopoulos MA, van Zyl G, et al
    HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: results from a national survey in South Africa.
    J Antimicrob Chemother. 2017;72:210-219.
    PubMed     Text format     Abstract available


  182. SHARMA A, Sharma R, Bhattacharyya T, Bhando T, et al
    Fosfomycin resistance in Acinetobacter baumannii is mediated by efflux through a major facilitator superfamily (MFS) transporter-AbaF.
    J Antimicrob Chemother. 2017;72:68-74.
    PubMed     Text format     Abstract available


  183. AMBROSIONI J, Nicolas D, Manzardo C, Aguero F, et al
    Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection.
    J Antimicrob Chemother. 2017;72:205-209.
    PubMed     Text format     Abstract available


    December 2016
  184. MORAN RA, Anantham S, Holt KE, Hall RM, et al
    Prediction of antibiotic resistance from antibiotic resistance genes detected in antibiotic-resistant commensal Escherichia coli using PCR or WGS.
    J Antimicrob Chemother. 2016 Dec 30. pii: dkw511. doi: 10.1093.
    PubMed     Text format     Abstract available


  185. RANDALL LB, Georgi E, Genzel GH, Schweizer HP, et al
    Finafloxacin overcomes Burkholderia pseudomallei efflux-mediated fluoroquinolone resistance.
    J Antimicrob Chemother. 2016 Dec 30. pii: dkw529. doi: 10.1093.
    PubMed     Text format    


  186. ZHU XQ, Wang XM, Li H, Shang YH, et al
    Novel lnu(G) gene conferring resistance to lincomycin by nucleotidylation, located on Tn6260 from Enterococcus faecalis E531.
    J Antimicrob Chemother. 2016 Dec 30. pii: dkw549. doi: 10.1093.
    PubMed     Text format     Abstract available


  187. VAN HAL SJ, Espedido BA, Coombs GW, Howden BP, et al
    Polyclonal emergence of vanA vancomycin-resistant Enterococcus faecium in Australia.
    J Antimicrob Chemother. 2016 Dec 28. pii: dkw539. doi: 10.1093.
    PubMed     Text format     Abstract available


  188. PENG H, Hu Q, Shang W, Yuan J, et al
    WalK(S221P), a naturally occurring mutation, confers vancomycin resistance in VISA strain XN108.
    J Antimicrob Chemother. 2016 Dec 20. pii: dkw518. doi: 10.1093.
    PubMed     Text format     Abstract available


  189. POMBA C, Rantala M, Greko C, Baptiste KE, et al
    Public health risk of antimicrobial resistance transfer from companion animals.
    J Antimicrob Chemother. 2016 Dec 20. pii: dkw481. doi: 10.1093.
    PubMed     Text format     Abstract available


  190. NAGU TJ, Aboud S, Matee MI, Maeurer MJ, et al
    Effects of isoniazid resistance on TB treatment outcomes under programmatic conditions in a high-TB and -HIV setting: a prospective multicentre study.
    J Antimicrob Chemother. 2016 Dec 20. pii: dkw503. doi: 10.1093.
    PubMed     Text format     Abstract available


  191. LAHRA MM, Trembizki E, Buckley C, Donovan B, et al
    Changes in the rates of Neisseria gonorrhoeae antimicrobial resistance are primarily driven by dynamic fluctuations in common gonococcal genotypes.
    J Antimicrob Chemother. 2016 Dec 20. pii: dkw452. doi: 10.1093.
    PubMed     Text format     Abstract available


  192. ROY CHOWDHURY P, Scott MJ, Djordjevic SP
    Genomic islands 1 and 2 carry multiple antibiotic resistance genes in Pseudomonas aeruginosa ST235, ST253, ST111 and ST175 and are globally dispersed.
    J Antimicrob Chemother. 2016 Dec 20. pii: dkw471. doi: 10.1093.
    PubMed     Text format    


  193. RIGHI E, Peri AM, Harris PN, Wailan AM, et al
    Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis.
    J Antimicrob Chemother. 2016 Dec 20. pii: dkw459. doi: 10.1093.
    PubMed     Text format     Abstract available


  194. KWONG JC, Schultz MB, Williamson DA, Stinear TP, et al
    Comment on: Benchmarking of methods for identification of antimicrobial resistance genes in bacterial whole genome data.
    J Antimicrob Chemother. 2016 Dec 20. pii: dkw473. doi: 10.1093.
    PubMed     Text format    


  195. BUTIN M, Martins-Simoes P, Pichon B, Leyssene D, et al
    Emergence and dissemination of a linezolid-resistant Staphylococcus capitis clone in Europe.
    J Antimicrob Chemother. 2016 Dec 20. pii: dkw516. doi: 10.1093.
    PubMed     Text format     Abstract available


  196. BRITT NS, Patel N, Shireman TI, El Atrouni WI, et al
    Relationship between vancomycin tolerance and clinical outcomes in Staphylococcus aureus bacteraemia.
    J Antimicrob Chemother. 2016 Dec 20. pii: dkw453. doi: 10.1093.
    PubMed     Text format     Abstract available


  197. CAVACO LM, Bernal JF, Zankari E, Leon M, et al
    Detection of linezolid resistance due to the optrA gene in Enterococcus faecalis from poultry meat from the American continent (Colombia).
    J Antimicrob Chemother. 2016 Dec 20. pii: dkw490. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2016
  198. BEETON ML, Spiller OB
    Antibiotic resistance among Ureaplasma spp. isolates: cause for concern?
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  199. GOIRE N, Kundu R, Trembizki E, Buckley C, et al
    Mixed gonococcal infections in a high-risk population, Sydney, Australia 2015: implications for antimicrobial resistance surveillance?
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  200. JEAN SS, Hsueh PR
    Distribution of ESBLs, AmpC beta-lactamases and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal and urinary tract infections in the Asia-Pacific region during 2008-14: results from the Study for Monitoring Antimicrobial Resist
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


    September 2016
  201. FALK L, Jensen JS
    Successful outcome of macrolide-resistant Mycoplasma genitalium urethritis after spectinomycin treatment: a case report.
    J Antimicrob Chemother. 2016.
    PubMed     Text format    


  202. DAY M, Doumith M, Jenkins C, Dallman TJ, et al
    Antimicrobial resistance in Shiga toxin-producing Escherichia coli serogroups O157 and O26 isolated from human cases of diarrhoeal disease in England, 2015.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  203. SCHMIDT K, Mwaigwisya S, Crossman LC, Doumith M, et al
    Identification of bacterial pathogens and antimicrobial resistance directly from clinical urines by nanopore-based metagenomic sequencing.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  204. MICALLEF C, Kildonaviciute K, Castro-Sanchez E, Scibor-Stepien A, et al
    Patient and public understanding and knowledge of antimicrobial resistance and stewardship in a UK hospital: should public campaigns change focus?
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  205. MULDER M, Kiefte-de Jong JC, Goessens WH, de Visser H, et al
    Risk factors for resistance to ciprofloxacin in community-acquired urinary tract infections due to Escherichia coli in an elderly population.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  206. KUBICEK-SUTHERLAND JZ, Lofton H, Vestergaard M, Hjort K, et al
    Antimicrobial peptide exposure selects for Staphylococcus aureus resistance to human defence peptides.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  207. LENHARD JR, Bulitta JB, Connell TD, King-Lyons N, et al
    High-intensity meropenem combinations with polymyxin B: new strategies to overcome carbapenem resistance in Acinetobacter baumannii.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  208. ARGUDIN MA, Dodemont M, Taguemount M, Roisin S, et al
    In vitro activity of ceftaroline against clinical Staphylococcus aureus isolates collected during a national survey conducted in Belgian hospitals.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  209. ZUSMAN O, Altunin S, Koppel F, Dishon Benattar Y, et al
    Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  210. PIETSCH F, Bergman JM, Brandis G, Marcusson LL, et al
    Ciprofloxacin selects for RNA polymerase mutations with pleiotropic antibiotic resistance effects.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  211. MORICI E, Simoni S, Brenciani A, Giovanetti E, et al
    A new mosaic integrative and conjugative element from Streptococcus agalactiae carrying resistance genes for chloramphenicol (catQ) and macrolides [mef(I) and erm(TR)].
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  212. MENDES RE, Castanheira M, Farrell DJ, Flamm RK, et al
    Longitudinal (2001-14) analysis of enterococci and VRE causing invasive infections in European and US hospitals, including a contemporary (2010-13) analysis of oritavancin in vitro potency.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  213. PINHOLT M, Gumpert H, Bayliss S, Nielsen JB, et al
    Genomic analysis of 495 vancomycin-resistant Enterococcus faecium reveals broad dissemination of a vanA plasmid in more than 19 clones from Copenhagen, Denmark.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  214. BERNARD C, Aubry A, Chauffour A, Brossier F, et al
    In vivo Mycobacterium tuberculosis fluoroquinolone resistance emergence: a complex phenomenon poorly detected by current diagnostic tests.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  215. DORADO-GARCIA A, Mevius DJ, Jacobs JJ, Van Geijlswijk IM, et al
    Quantitative assessment of antimicrobial resistance in livestock during the course of a nationwide antimicrobial use reduction in the Netherlands.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  216. FUURSTED K, Stegger M, Hoffmann S, Lambertsen L, et al
    Description and characterization of a penicillin-resistant Streptococcus dysgalactiae subsp. equisimilis clone isolated from blood in three epidemiologically linked patients.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  217. NAIR S, Ashton P, Doumith M, Connell S, et al
    WGS for surveillance of antimicrobial resistance: a pilot study to detect the prevalence and mechanism of resistance to azithromycin in a UK population of non-typhoidal Salmonella.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


    August 2016
  218. LE PAGE S, Dubourg G, Rolain JM
    Evaluation of the Scan(R) 1200 as a rapid tool for reading antibiotic susceptibility testing by the disc diffusion technique.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  219. TORUMKUNEY D, Chaiwarith R, Reechaipichitkul W, Malatham K, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2012-14 in Thailand, India, South Korea and Singapore.
    J Antimicrob Chemother. 2016.
    PubMed     Text format    


  220. CARTER GP, Buultjens AH, Ballard SA, Baines SL, et al
    Emergence of endemic MLST non-typeable vancomycin-resistant Enterococcus faecium.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  221. FRAVEGA J, Alvarez R, Diaz F, Inostroza O, et al
    Salmonella Typhimurium exhibits fluoroquinolone resistance mediated by the accumulation of the antioxidant molecule H2S in a CysK-dependent manner.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  222. CHONG GM, van der Beek MT, von dem Borne PA, Boelens J, et al
    PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay(R) in 201 patients with haematological disease suspected for invasive aspergillosis.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  223. HUA X, Shu J, Ruan Z, Yu Y, et al
    Multiplication of blaOXA-23 is common in clinical Acinetobacter baumannii, but does not enhance carbapenem resistance.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  224. LAHIRI SD, Alm RA
    Identification of non-PBP2a resistance mechanisms in Staphylococcus aureus after serial passage with ceftaroline: involvement of other PBPs.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  225. WARBURTON PJ, Amodeo N, Roberts AP
    Mosaic tetracycline resistance genes encoding ribosomal protection proteins.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  226. VERWEIJ PE, Lestrade PP, Melchers WJ, Meis JF, et al
    Azole resistance surveillance in Aspergillus fumigatus: beneficial or biased?
    J Antimicrob Chemother. 2016;71:2079-82.
    PubMed     Text format     Abstract available


  227. ALANIO A, Denis B, Hamane S, Raffoux E, et al
    New therapeutic strategies for invasive aspergillosis in the era of azole resistance: how should the prevalence of azole resistance be defined?
    J Antimicrob Chemother. 2016;71:2075-8.
    PubMed     Text format     Abstract available


    July 2016
  228. MACHUCA J, Ortiz M, Recacha E, Diaz-De-Alba P, et al
    Impact of AAC(6')-Ib-cr in combination with chromosomal-mediated mechanisms on clinical quinolone resistance in Escherichia coli.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  229. TSAO S, Weber S, Cameron C, Nehme D, et al
    Positive regulation of the Candida albicans multidrug efflux pump Cdr1p function by phosphorylation of its N-terminal extension.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


    June 2016
  230. CLAUSEN PT, Zankari E, Aarestrup FM, Lund O, et al
    Benchmarking of methods for identification of antimicrobial resistance genes in bacterial whole genome data.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  231. CHIN TL, McNulty C, Beck C, MacGowan A, et al
    Antimicrobial resistance surveillance in urinary tract infections in primary care.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  232. SINEL C, Cosquer T, Auzou M, Goux D, et al
    Sequential steps of daptomycin resistance in Enterococcus faecium and reversion to hypersusceptibility through IS-mediated inactivation of the liaFSR operon.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  233. KIM J, Han X, Bae J, Chui L, et al
    Prevalence of plasmid-mediated quinolone resistance (PMQR) genes in non-typhoidal Salmonella strains with resistance and reduced susceptibility to fluoroquinolones from human clinical cases in Alberta, Canada, 2009-13.
    J Antimicrob Chemother. 2016.
    PubMed     Text format    


  234. KARLSSON E, Golovliov I, Larkeryd A, Granberg M, et al
    Clonality of erythromycin resistance in Francisella tularensis.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  235. CONCEICAO T, de Lencastre H, Aires-de-Sousa M
    Efficacy of octenidine against antibiotic-resistant Staphylococcus aureus epidemic clones.
    J Antimicrob Chemother. 2016.
    PubMed     Text format    


  236. HAMPRECHT A, Rohde AM, Behnke M, Feihl S, et al
    Colonization with third-generation cephalosporin-resistant Enterobacteriaceae on hospital admission: prevalence and risk factors.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  237. BAR-YOSEPH H, Hussein K, Braun E, Paul M, et al
    Natural history and decolonization strategies for ESBL/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  238. PFALLER MA, Messer SA, Rhomberg PR, Jones RN, et al
    Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  239. CHUNG M, Kim CK, Conceicao T, Aires-De-Sousa M, et al
    Heterogeneous oxacillin-resistant phenotypes and production of PBP2A by oxacillin-susceptible/mecA-positive MRSA strains from Africa.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  240. EILERTSON B, Maruri F, Blackman A, Guo Y, et al
    A novel resistance mutation in eccC5 of the ESX-5 secretion system confers ofloxacin resistance in Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  241. INZAULE SC, Weidle PJ, Yang C, Ndiege K, et al
    Prevalence and dynamics of the K65R drug resistance mutation in HIV-1-infected infants exposed to maternal therapy with lamivudine, zidovudine and either nevirapine or nelfinavir in breast milk.
    J Antimicrob Chemother. 2016;71:1619-26.
    PubMed     Text format     Abstract available


  242. SENNATI S, Riccobono E, Di Pilato V, Villagran AL, et al
    pHN7A8-related multiresistance plasmids (blaCTX-M-65, fosA3 and rmtB) detected in clinical isolates of Klebsiella pneumoniae from Bolivia: intercontinental plasmid dissemination?
    J Antimicrob Chemother. 2016;71:1732-4.
    PubMed     Text format    


  243. SANCHEZ EH, Mendes RE, Sader HS, Allison GM, et al
    In vivo emergence of ceftaroline resistance during therapy for MRSA vertebral osteomyelitis.
    J Antimicrob Chemother. 2016;71:1736-8.
    PubMed     Text format    


  244. SAW HT, Webber MA, Mushtaq S, Woodford N, et al
    Inactivation or inhibition of AcrAB-TolC increases resistance of carbapenemase-producing Enterobacteriaceae to carbapenems.
    J Antimicrob Chemother. 2016;71:1510-9.
    PubMed     Text format     Abstract available


  245. FERNANDEZ J, Poirel L, Rodicio MR, Nordmann P, et al
    Concomitant and multiclonal dissemination of OXA-48-producing Klebsiella pneumoniae in a Spanish hospital.
    J Antimicrob Chemother. 2016;71:1734-6.
    PubMed     Text format    


    May 2016
  246. NIGRO SJ, Hall RM
    Loss and gain of aminoglycoside resistance in global clone 2 Acinetobacter baumannii in Australia via modification of genomic resistance islands and acquisition of plasmids.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  247. VERHOEF L, Roukens M, de Greeff S, Meessen N, et al
    Carriage of antimicrobial-resistant commensal bacteria in Dutch long-term-care facilities.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  248. SEROY JT, Grim SA, Reid GE, Wellington T, et al
    Treatment of MDR urinary tract infections with oral fosfomycin: a retrospective analysis.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  249. PANTEL A, Petrella S, Veziris N, Matrat S, et al
    Description of compensatory gyrA mutations restoring fluoroquinolone susceptibility in Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  250. MONNET DL, Safrany N, Heine N, Price C, et al
    Comment on: A systematic review of the public's knowledge and beliefs about antibiotic resistance.
    J Antimicrob Chemother. 2016.
    PubMed     Text format    


  251. FREIRE MP, de Oliveira Garcia D, Cury AP, Spadao F, et al
    Outbreak of IMP-producing carbapenem-resistant Enterobacter gergoviae among kidney transplant recipients.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  252. MCCULLOUGH AR, Parekh S, Rathbone J, Del Mar CB, et al
    A systematic review of the public's knowledge and beliefs about antibiotic resistance-authors' response.
    J Antimicrob Chemother. 2016.
    PubMed     Text format    


  253. DOBIASOVA H, Dolejska M
    Prevalence and diversity of IncX plasmids carrying fluoroquinolone and beta-lactam resistance genes in Escherichia coli originating from diverse sources and geographical areas.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  254. LIU P, Xue H, Wu Z, Ma J, et al
    Effect of bla regulators on the susceptible phenotype and phenotypic conversion for oxacillin-susceptible mecA-positive staphylococcal isolates.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  255. MOUGARI F, Amarsy R, Veziris N, Bastian S, et al
    Standardized interpretation of antibiotic susceptibility testing and resistance genotyping for Mycobacterium abscessus with regard to subspecies and erm41 sequevar.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  256. VAN PH, Binh PT, Minh NH, Morrissey I, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2009-11 in Vietnam.
    J Antimicrob Chemother. 2016;71 Suppl 1:i93-i102.
    PubMed     Text format     Abstract available


  257. TORUMKUNEY D, Gur D, Soyletir G, Gurler N, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2002-09 in Turkey.
    J Antimicrob Chemother. 2016;71 Suppl 1:i85-i91.
    PubMed     Text format     Abstract available


  258. SOYLETIR G, Altinkanat G, Gur D, Altun B, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2011-13 in Turkey.
    J Antimicrob Chemother. 2016;71 Suppl 1:i71-i83.
    PubMed     Text format     Abstract available


  259. FESHCHENKO Y, Dzyublik A, Pertseva T, Bratus E, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2011-13 in Ukraine.
    J Antimicrob Chemother. 2016;71 Suppl 1:i63-i69.
    PubMed     Text format     Abstract available


  260. JAMSHEER A, Rafay AM, Daoud Z, Morrissey I, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2011-13 in the Gulf States.
    J Antimicrob Chemother. 2016;71 Suppl 1:i45-i61.
    PubMed     Text format     Abstract available


  261. HU F, Zhu D, Wang F, Morrissey I, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2009-11 and 2013-14 in China.
    J Antimicrob Chemother. 2016;71 Suppl 1:i33-i43.
    PubMed     Text format     Abstract available


  262. TORUMKUNEY D, Chaiwarith R, Reechaipichitkul W, Malatham K, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2012-14 in Thailand, India, South Korea and Singapore.
    J Antimicrob Chemother. 2016;71 Suppl 1:i3-i19.
    PubMed     Text format     Abstract available


  263. KACOU-NDOUBA A, Revathi G, Mwathi P, Seck A, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2011-14 in the Democratic Republic of Congo, Ivory Coast, Republic of Senegal and Kenya.
    J Antimicrob Chemother. 2016;71 Suppl 1:i21-i31.
    PubMed     Text format     Abstract available


  264. ZAFAR A, Hasan R, Nizamuddin S, Mahmood N, et al
    Antibiotic susceptibility in Streptococcus pneumoniae, Haemophilus influenzae and Streptococcus pyogenes in Pakistan: a review of results from the Survey of Antibiotic Resistance (SOAR) 2002-15.
    J Antimicrob Chemother. 2016;71 Suppl 1:i103-i109.
    PubMed     Text format     Abstract available


  265. ENNE VI, Johnson AP, Perry JD
    Preface.
    J Antimicrob Chemother. 2016;71 Suppl 1:i1.
    PubMed     Text format    


  266. ARIEN KK, Venkatraj M, Michiels J, Joossens J, et al
    Resistance and cross-resistance profile of the diaryltriazine NNRTI and candidate microbicide UAMC01398.
    J Antimicrob Chemother. 2016;71:1159-68.
    PubMed     Text format     Abstract available


  267. JOST C, Bidet P, Carrere T, Mariani-Kurkdjian P, et al
    Susceptibility of enterohaemorrhagic Escherichia coli to azithromycin in France and analysis of resistance mechanisms.
    J Antimicrob Chemother. 2016;71:1183-7.
    PubMed     Text format     Abstract available


  268. LI L, Hassan KA, Brown MH, Paulsen IT, et al
    Rapid multiplexed phenotypic screening identifies drug resistance functions for three novel efflux pumps in Acinetobacter baumannii.
    J Antimicrob Chemother. 2016;71:1223-32.
    PubMed     Text format     Abstract available


  269. BATHOORN E, Tsioutis C, da Silva Voorham JM, Scoulica EV, et al
    Emergence of pan-resistance in KPC-2 carbapenemase-producing Klebsiella pneumoniae in Crete, Greece: a close call.
    J Antimicrob Chemother. 2016;71:1207-12.
    PubMed     Text format     Abstract available


  270. ROWLEY CF, MacLeod IJ, Maruapula D, Lekoko B, et al
    Sharp increase in rates of HIV transmitted drug resistance at antenatal clinics in Botswana demonstrates the need for routine surveillance.
    J Antimicrob Chemother. 2016;71:1361-6.
    PubMed     Text format     Abstract available


  271. PHAM QD, Wilson DP, Nguyen TV, Do NT, et al
    Projecting the epidemiological effect, cost-effectiveness and transmission of HIV drug resistance in Vietnam associated with viral load monitoring strategies.
    J Antimicrob Chemother. 2016;71:1367-79.
    PubMed     Text format     Abstract available


  272. LINKEVICIUS M, Anderssen JM, Sandegren L, Andersson DI, et al
    Fitness of Escherichia coli mutants with reduced susceptibility to tigecycline.
    J Antimicrob Chemother. 2016;71:1307-13.
    PubMed     Text format     Abstract available


  273. MOHAMED AF, Kristoffersson AN, Karvanen M, Nielsen EI, et al
    Dynamic interaction of colistin and meropenem on a WT and a resistant strain of Pseudomonas aeruginosa as quantified in a PK/PD model.
    J Antimicrob Chemother. 2016;71:1279-90.
    PubMed     Text format     Abstract available


  274. BRASSEUR A, Hites M, Roisin S, Cotton F, et al
    A high-dose aminoglycoside regimen combined with renal replacement therapy for the treatment of MDR pathogens: a proof-of-concept study.
    J Antimicrob Chemother. 2016;71:1386-94.
    PubMed     Text format     Abstract available


  275. DE LUCA A, Flandre P, Dunn D, Zazzi M, et al
    Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen.
    J Antimicrob Chemother. 2016;71:1352-60.
    PubMed     Text format     Abstract available


  276. MURATA S, Mushino T, Hosoi H, Kuriyama K, et al
    Extracorporeal antimicrobial elimination enables antimicrobial mixing and affects resident bacteria.
    J Antimicrob Chemother. 2016;71:1430-2.
    PubMed     Text format    


    April 2016
  277. MICHOS A, Koutouzi FI, Tsakris A, Chatzichristou P, et al
    Molecular analysis of Streptococcus pyogenes macrolide resistance of paediatric isolates during a 7 year period (2007-13).
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  278. GOMEZ-SIMMONDS A, Hu Y, Sullivan SB, Wang Z, et al
    Evidence from a New York City hospital of rising incidence of genetically diverse carbapenem-resistant Enterobacter cloacae and dominance of ST171, 2007-14.
    J Antimicrob Chemother. 2016.
    PubMed     Text format    


  279. DEPLANO A, Vandendriessche S, Nonhoff C, Dodemont M, et al
    National surveillance of Staphylococcus epidermidis recovered from bloodstream infections in Belgian hospitals.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  280. HONG J, Shu X, Liu D, Zhu Y, et al
    Antibiotic resistance and CYP2C19 polymorphisms affect the efficacy of concomitant therapies for Helicobacter pylori infection: an open-label, randomized, single-centre clinical trial.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  281. REULAND EA, Al Naiemi N, Kaiser AM, Heck M, et al
    Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in Amsterdam.
    J Antimicrob Chemother. 2016;71:1076-82.
    PubMed     Text format     Abstract available


  282. GUBAVU C, Prazuck T, Niang M, Buret J, et al
    Dolutegravir-based monotherapy or dual therapy maintains a high proportion of viral suppression even in highly experienced HIV-1-infected patients.
    J Antimicrob Chemother. 2016;71:1046-50.
    PubMed     Text format     Abstract available


  283. LAMBERT-NICLOT S, George EC, Pozniak A, White E, et al
    Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART.
    J Antimicrob Chemother. 2016;71:1056-62.
    PubMed     Text format     Abstract available


  284. POND MJ, Hall CL, Miari VF, Cole M, et al
    Accurate detection of Neisseria gonorrhoeae ciprofloxacin susceptibility directly from genital and extragenital clinical samples: towards genotype-guided antimicrobial therapy.
    J Antimicrob Chemother. 2016;71:897-902.
    PubMed     Text format     Abstract available


  285. CROWTHER GS, Chilton CH, Longshaw C, Todhunter SL, et al
    Efficacy of vancomycin extended-dosing regimens for treatment of simulated Clostridium difficile infection within an in vitro human gut model.
    J Antimicrob Chemother. 2016;71:986-91.
    PubMed     Text format     Abstract available


  286. SKURNIK D, Roux D, Pons S, Guillard T, et al
    Extended-spectrum antibodies protective against carbapenemase-producing Enterobacteriaceae.
    J Antimicrob Chemother. 2016;71:927-35.
    PubMed     Text format     Abstract available


  287. BEN YAAKOV D, Rivkin A, Mircus G, Albert N, et al
    Identification and characterization of haemofungin, a novel antifungal compound that inhibits the final step of haem biosynthesis.
    J Antimicrob Chemother. 2016;71:946-52.
    PubMed     Text format     Abstract available


  288. GUO Q, Spychala CN, McElheny CL, Doi Y, et al
    Comparative analysis of an IncR plasmid carrying armA, blaDHA-1 and qnrB4 from Klebsiella pneumoniae ST37 isolates.
    J Antimicrob Chemother. 2016;71:882-6.
    PubMed     Text format     Abstract available


  289. SUN F, Zhou D, Wang Q, Feng J, et al
    Genetic characterization of a novel blaDIM-2-carrying megaplasmid p12969-DIM from clinical Pseudomonas putida.
    J Antimicrob Chemother. 2016;71:909-12.
    PubMed     Text format     Abstract available


    March 2016
  290. MEUNIER D, Doumith M, Findlay J, Mustafa N, et al
    Carbapenem resistance mediated by blaOXA-181 in Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2016.
    PubMed     Text format    


  291. HUNTINGTON JA, Sakoulas G, Umeh O, Cloutier DJ, et al
    Efficacy of ceftolozane/tazobactam versus levofloxacin in the treatment of complicated urinary tract infections (cUTIs) caused by levofloxacin-resistant pathogens: results from the ASPECT-cUTI trial.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  292. LIN YT, Tsai JC, Yamamoto T, Chen HJ, et al
    Emergence of a small colony variant of vancomycin-intermediate Staphylococcus aureus in a patient with septic arthritis during long-term treatment with daptomycin.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  293. ANASTASI E, Giguere S, Berghaus LJ, Hondalus MK, et al
    Novel transferable erm(46) determinant responsible for emerging macrolide resistance in Rhodococcus equi.
    J Antimicrob Chemother. 2016.
    PubMed     Text format    


  294. LI D, Wang Y, Schwarz S, Cai J, et al
    Co-location of the oxazolidinone resistance genes optrA and cfr on a multiresistance plasmid from Staphylococcus sciuri.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  295. COUTO N, Monchique C, Belas A, Marques C, et al
    Trends and molecular mechanisms of antimicrobial resistance in clinical staphylococci isolated from companion animals over a 16 year period.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  296. HAMIDIAN M, Hall RM
    The resistance gene complement of D4, a multiply antibiotic-resistant ST25 Acinetobacter baumannii isolate, resides in two genomic islands and a plasmid.
    J Antimicrob Chemother. 2016.
    PubMed     Text format    


  297. THOMPSON CN, Thieu NT, Vinh PV, Duc AN, et al
    Clinical implications of reduced susceptibility to fluoroquinolones in paediatric Shigella sonnei and Shigella flexneri infections.
    J Antimicrob Chemother. 2016;71:807-15.
    PubMed     Text format     Abstract available


  298. DI MAIO VC, Cento V, Di Paolo D, Aragri M, et al
    HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels.
    J Antimicrob Chemother. 2016;71:739-50.
    PubMed     Text format     Abstract available


  299. FABREGA A, Balleste-Delpierre C, Vila J
    Differential impact of ramRA mutations on both ramA transcription and decreased antimicrobial susceptibility in Salmonella Typhimurium.
    J Antimicrob Chemother. 2016;71:617-24.
    PubMed     Text format     Abstract available


  300. CAMPOS J, Mourao J, Marcal S, Machado J, et al
    Clinical Salmonella Typhimurium ST34 with metal tolerance genes and an IncHI2 plasmid carrying oqxAB-aac(6')-Ib-cr from Europe.
    J Antimicrob Chemother. 2016;71:843-5.
    PubMed     Text format    


  301. GANTNER P, Morand-Joubert L, Sueur C, Raffi F, et al
    Drug resistance and tropism as markers of the dynamics of HIV-1 DNA quasispecies in blood cells of heavily pretreated patients who achieved sustained virological suppression.
    J Antimicrob Chemother. 2016;71:751-61.
    PubMed     Text format     Abstract available


  302. THAO VP, Quang VM, Day JN, Chinh NT, et al
    High prevalence of PI resistance in patients failing second-line ART in Vietnam.
    J Antimicrob Chemother. 2016;71:762-74.
    PubMed     Text format     Abstract available


  303. KOMP LINDGREN P, Higgins PG, Seifert H, Cars O, et al
    Prevalence of hypermutators among clinical Acinetobacter baumannii isolates.
    J Antimicrob Chemother. 2016;71:661-5.
    PubMed     Text format     Abstract available


  304. YOON EJ, Goussard S, Nemec A, Lambert T, et al
    Origin in Acinetobacter gyllenbergii and dissemination of aminoglycoside-modifying enzyme AAC(6')-Ih.
    J Antimicrob Chemother. 2016;71:601-6.
    PubMed     Text format     Abstract available


  305. STRUKOVA EN, Portnoy YA, Zinner SH, Firsov AA, et al
    Predictors of bacterial resistance using in vitro dynamic models: area under the concentration-time curve related to either the minimum inhibitory or mutant prevention antibiotic concentration.
    J Antimicrob Chemother. 2016;71:678-84.
    PubMed     Text format     Abstract available


  306. FLOREZ-CUADRADO D, Ugarte-Ruiz M, Quesada A, Palomo G, et al
    Description of an erm(B)-carrying Campylobacter coli isolate in Europe.
    J Antimicrob Chemother. 2016;71:841-3.
    PubMed     Text format    


  307. WANG Y, Dong Y, Deng F, Liu D, et al
    Species shift and multidrug resistance of Campylobacter from chicken and swine, China, 2008-14.
    J Antimicrob Chemother. 2016;71:666-9.
    PubMed     Text format     Abstract available


  308. HALL RM, Schwarz S
    Resistance gene naming and numbering: is it a new gene or not?
    J Antimicrob Chemother. 2016;71:569-71.
    PubMed     Text format     Abstract available


    February 2016
  309. ZIMENKOV DV, Kulagina EV, Antonova OV, Zhuravlev VY, et al
    Simultaneous drug resistance detection and genotyping of Mycobacterium tuberculosis using a low-density hydrogel microarray.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  310. HE T, Shen Y, Schwarz S, Cai J, et al
    Genetic environment of the transferable oxazolidinone/phenicol resistance gene optrA in Enterococcus faecalis isolates of human and animal origin.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  311. GUY R, Geoghegan L, Heginbothom M, Howe R, et al
    Non-susceptibility of Escherichia coli, Klebsiella spp., Pseudomonas spp., Streptococcus pneumoniae and Staphylococcus aureus in the UK: temporal trends in England, Northern Ireland, Scotland and Wales.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  312. ADLER M, Anjum M, Andersson DI, Sandegren L, et al
    Combinations of mutations in envZ, ftsI, mrdA, acrB and acrR can cause high-level carbapenem resistance in Escherichia coli.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  313. LLACER DELICADO T, Torrecilla E, Holguin A
    Deep analysis of HIV-1 natural variability across HIV-1 variants at residues associated with integrase inhibitor (INI) resistance in INI-naive individuals.
    J Antimicrob Chemother. 2016;71:362-6.
    PubMed     Text format     Abstract available


  314. BUCKLEY C, Trembizki E, Donovan B, Chen M, et al
    A real-time PCR assay for direct characterization of the Neisseria gonorrhoeae GyrA 91 locus associated with ciprofloxacin susceptibility.
    J Antimicrob Chemother. 2016;71:353-6.
    PubMed     Text format     Abstract available


  315. STEININGER C, Willinger B
    Resistance patterns in clinical isolates of pathogenic Actinomyces species.
    J Antimicrob Chemother. 2016;71:422-7.
    PubMed     Text format     Abstract available


  316. ALHASHASH F, Wang X, Paszkiewicz K, Diggle M, et al
    Increase in bacteraemia cases in the East Midlands region of the UK due to MDR Escherichia coli ST73: high levels of genomic and plasmid diversity in causative isolates.
    J Antimicrob Chemother. 2016;71:339-43.
    PubMed     Text format     Abstract available


  317. NEOGI U, Haggblom A, Singh K, Rogers LC, et al
    Factors influencing the efficacy of rilpivirine in HIV-1 subtype C in low- and middle-income countries.
    J Antimicrob Chemother. 2016;71:367-71.
    PubMed     Text format     Abstract available


  318. LANDELLE C, von Dach E, Haustein T, Agostinho A, et al
    Randomized, placebo-controlled, double-blind clinical trial to evaluate the efficacy of polyhexanide for topical decolonization of MRSA carriers.
    J Antimicrob Chemother. 2016;71:531-8.
    PubMed     Text format     Abstract available


  319. RAWSON TM, Moore LS, Gilchrist MJ, Holmes AH, et al
    Antimicrobial stewardship: are we failing in cross-specialty clinical engagement?
    J Antimicrob Chemother. 2016;71:554-9.
    PubMed     Text format     Abstract available


  320. VICIANA I, Gonzalez-Domenech CM, Palacios R, Delgado M, et al
    Clinical, virological and phylogenetic characterization of a multiresistant HIV-1 strain outbreak in naive patients in southern Spain.
    J Antimicrob Chemother. 2016;71:357-61.
    PubMed     Text format     Abstract available


  321. BRENCIANI A, Morroni G, Pollini S, Tiberi E, et al
    Characterization of novel conjugative multiresistance plasmids carrying cfr from linezolid-resistant Staphylococcus epidermidis clinical isolates from Italy.
    J Antimicrob Chemother. 2016;71:307-13.
    PubMed     Text format     Abstract available


    January 2016
  322. KOLACZKOWSKA A, Kolaczkowski M
    Drug resistance mechanisms and their regulation in non-albicans Candida species.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  323. PFEIFER Y, Hunfeld KP, Borgmann S, Maneg D, et al
    Carbapenem-resistant Acinetobacter baumannii ST78 with OXA-72 carbapenemase and ESBL gene blaCTX-M-115.
    J Antimicrob Chemother. 2016.
    PubMed     Text format    


  324. VERSPORTEN A, Bielicki J, Drapier N, Sharland M, et al
    The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for children.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  325. JAYOL A, Janvier F, Guillard T, Chau F, et al
    qnrA6 genetic environment and quinolone resistance conferred on Proteus mirabilis.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  326. DONNELLY JP
    Editorial: Celebrating 40 years of the Journal.
    J Antimicrob Chemother. 2016;71:1-2.
    PubMed     Text format    


  327. CHEN SC, Yin YP, Dai XQ, Unemo M, et al
    First nationwide study regarding ceftriaxone resistance and molecular epidemiology of Neisseria gonorrhoeae in China.
    J Antimicrob Chemother. 2016;71:92-9.
    PubMed     Text format     Abstract available


  328. PULE CM, Sampson SL, Warren RM, Black PA, et al
    Efflux pump inhibitors: targeting mycobacterial efflux systems to enhance TB therapy.
    J Antimicrob Chemother. 2016;71:17-26.
    PubMed     Text format     Abstract available


  329. BORTOLIN M, De Vecchi E, Romano CL, Toscano M, et al
    Antibiofilm agents against MDR bacterial strains: is bioactive glass BAG-S53P4 also effective?
    J Antimicrob Chemother. 2016;71:123-7.
    PubMed     Text format     Abstract available


  330. HARRISON EM, Ba X, Blane B, Ellington MJ, et al
    PBP2a substitutions linked to ceftaroline resistance in MRSA isolates from the UK.
    J Antimicrob Chemother. 2016;71:268-9.
    PubMed     Text format    


  331. SCHAUMBURG F, Peters G, Alabi A, Becker K, et al
    Missense mutations of PBP2a are associated with reduced susceptibility to ceftaroline and ceftobiprole in African MRSA.
    J Antimicrob Chemother. 2016;71:41-4.
    PubMed     Text format     Abstract available


  332. SAUERBREI A, Bohn-Wippert K, Kaspar M, Krumbholz A, et al
    Database on natural polymorphisms and resistance-related non-synonymous mutations in thymidine kinase and DNA polymerase genes of herpes simplex virus types 1 and 2.
    J Antimicrob Chemother. 2016;71:6-16.
    PubMed     Text format     Abstract available


  333. ANTONELLI A, D'Andrea MM, Montagnani C, Bartolesi AM, et al
    Newborn bacteraemia caused by an Aeromonas caviae producing the VIM-1 and SHV-12 beta-lactamases, encoded by a transferable plasmid.
    J Antimicrob Chemother. 2016;71:272-4.
    PubMed     Text format    


  334. LAI CC, Liu WC, Fang CT, Yang JY, et al
    Transmitted drug resistance of HIV-1 strains among individuals attending voluntary counselling and testing in Taiwan.
    J Antimicrob Chemother. 2016;71:226-34.
    PubMed     Text format     Abstract available


    December 2015
  335. BRENCIANI A, Morroni G, Vincenzi C, Manso E, et al
    Detection in Italy of two clinical Enterococcus faecium isolates carrying both the oxazolidinone and phenicol resistance gene optrA and a silent multiresistance gene cfr.
    J Antimicrob Chemother. 2015.
    PubMed     Text format    


  336. FIEDLER S, Bender JK, Klare I, Halbedel S, et al
    Tigecycline resistance in clinical isolates of Enterococcus faecium is mediated by an upregulation of plasmid-encoded tetracycline determinants tet(L) and tet(M).
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  337. MINGOIA M, Morici E, Marini E, Brenciani A, et al
    Macrolide resistance gene erm(TR) and erm(TR)-carrying genetic elements in Streptococcus agalactiae: characterization of ICESagTR7, a new composite element containing IMESp2907.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  338. LOOTS DT
    New insights into the survival mechanisms of rifampicin-resistant Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  339. CAFINI F, Nguyen LT, Higashide M, Roman F, et al
    Horizontal gene transmission of the cfr gene to MRSA and Enterococcus: role of Staphylococcus epidermidis as a reservoir and alternative pathway for the spread of linezolid resistance.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


    November 2015
  340. BIELICKI JA, Sharland M, Johnson AP, Henderson KL, et al
    Selecting appropriate empirical antibiotic regimens for paediatric bloodstream infections: application of a Bayesian decision model to local and pooled antimicrobial resistance surveillance data.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  341. RODRIGUEZ-MARTINEZ JM, Lopez-Cerero L, Diaz-de-Alba P, Chamizo-Lopez FJ, et al
    Assessment of a phenotypic algorithm to detect plasmid-mediated quinolone resistance in Enterobacteriaceae.
    J Antimicrob Chemother. 2015.
    PubMed     Text format    


  342. YANG CJ, Tang HJ, Chang SY, Hsieh SM, et al
    Comparison of serological responses to single-dose azithromycin (2 g) versus benzathine penicillin G in the treatment of early syphilis in HIV-infected patients in an area of low prevalence of macrolide-resistant Treponema pallidum infection.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  343. TUCHSCHERR L, Kreis CA, Hoerr V, Flint L, et al
    Staphylococcus aureus develops increased resistance to antibiotics by forming dynamic small colony variants during chronic osteomyelitis.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  344. KOSTYANEV T, Bonten MJ, O'Brien S, Steel H, et al
    The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


    October 2015
  345. LAHIRI SD, Alm RA
    Potential of Staphylococcus aureus isolates carrying different PBP2a alleles to develop resistance to ceftaroline.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  346. BARBER KE, Smith JR, Raut A, Rybak MJ, et al
    Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


    September 2015
  347. DOUARRE PE, Sauvage E, Poyart C, Glaser P, et al
    Host specificity in the diversity and transfer of lsa resistance genes in group B Streptococcus.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  348. NAGANT C, Deplano A, Nonhoff C, De Mendonca R, et al
    Low prevalence of mupirocin resistance in Belgian Staphylococcus aureus isolates collected during a 10 year nationwide surveillance.
    J Antimicrob Chemother. 2015.
    PubMed     Text format    


  349. TREVINO SE, Babcock HM, Henderson JP, Lane MA, et al
    Perceptions and behaviours of infectious diseases physicians when managing urinary tract infections due to MDR organisms.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


    August 2015
  350. CONCEICAO T, Coelho C, de Lencastre H, Aires-de-Sousa M, et al
    Frequent occurrence of oxacillin-susceptible mecA-positive Staphylococcus aureus (OS-MRSA) strains in two African countries.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


    July 2015
  351. BAX HI, de Steenwinkel JE, Ten Kate MT, van der Meijden A, et al
    Colistin as a potentiator of anti-TB drug activity against Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  352. LUPIEN A, Gingras H, Leprohon P, Ouellette M, et al
    Induced tigecycline resistance in Streptococcus pneumoniae mutants reveals mutations in ribosomal proteins and rRNA.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  353. SEKI T, Kimura K, Reid ME, Miyazaki A, et al
    High isolation rate of MDR group B streptococci with reduced penicillin susceptibility in Japan.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  354. FUHREN J, Voskuil WS, Boel CH, Haas PJ, et al
    High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  355. AGUINAGALDE L, Diez-Martinez R, Yuste J, Royo I, et al
    Auranofin efficacy against MDR Streptococcus pneumoniae and Staphylococcus aureus infections.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  356. FRANGE P, Assoumou L, Descamps D, Cheret A, et al
    HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies.
    J Antimicrob Chemother. 2015;70:2084-9.
    PubMed     Text format     Abstract available


  357. XING H, Ruan Y, Hsi JH, Kan W, et al
    Reductions in virological failure and drug resistance in Chinese antiretroviral-treated patients due to lamivudine-based regimens, 2003-12.
    J Antimicrob Chemother. 2015;70:2097-103.
    PubMed     Text format     Abstract available


  358. PFENNIGWERTH N, Geis G, Gatermann SG, Kaase M, et al
    Description of IMP-31, a novel metallo-beta-lactamase found in an ST235 Pseudomonas aeruginosa strain in Western Germany.
    J Antimicrob Chemother. 2015;70:1973-80.
    PubMed     Text format     Abstract available


  359. VIDAL LL, Santos AF, Soares MA
    Worldwide distribution of the NS3 gene 80K polymorphism among circulating hepatitis C genotype 1 viruses: implication for simeprevir usage.
    J Antimicrob Chemother. 2015;70:2024-7.
    PubMed     Text format     Abstract available


  360. BERTHET N, Perichon B, Mazuet C, Chapeton-Montes D, et al
    A vanG-type locus in Clostridium argentinense.
    J Antimicrob Chemother. 2015;70:1942-5.
    PubMed     Text format     Abstract available


  361. FARRUKEE R, Leang SK, Butler J, Lee RT, et al
    Influenza viruses with B/Yamagata- and B/Victoria-like neuraminidases are differentially affected by mutations that alter antiviral susceptibility.
    J Antimicrob Chemother. 2015;70:2004-12.
    PubMed     Text format     Abstract available


  362. CHARPENTIER C, Lee GQ, Rodriguez C, Visseaux B, et al
    Highly frequent HIV-1 minority resistant variants at baseline of the ANRS 139 TRIO trial had a limited impact on virological response.
    J Antimicrob Chemother. 2015;70:2090-6.
    PubMed     Text format     Abstract available


    June 2015
  363. ZHANG S, Chen J, Cui P, Shi W, et al
    Identification of novel mutations associated with clofazimine resistance in Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


    May 2015
  364. GARNAUD C, Botterel F, Sertour N, Bougnoux ME, et al
    Next-generation sequencing offers new insights into the resistance of Candida spp. to echinocandins and azoles.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  365. JENSEN RH, Astvad KM, Silva LV, Sanglard D, et al
    Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistance in vivo in Candida albicans orchestrated by multiple genetic alterations.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  366. WANG Y, Lv Y, Cai J, Schwarz S, et al
    A novel gene, optrA, that confers transferable resistance to oxazolidinones and phenicols and its presence in Enterococcus faecalis and Enterococcus faecium of human and animal origin.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  367. MARTINEZ E, Holmes N, Jelfs P, Sintchenko V, et al
    Genome sequencing reveals novel deletions associated with secondary resistance to pyrazinamide in MDR Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  368. LY NS, Bulitta JB, Rao GG, Landersdorfer CB, et al
    Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance.
    J Antimicrob Chemother. 2015;70:1434-42.
    PubMed     Text format     Abstract available


  369. ZHANG XM, Wu H, Zhang Q, Lau TC, et al
    A novel mutation, D404N, in the connection subdomain of reverse transcriptase of HIV-1 CRF08_BC subtype confers cross-resistance to NNRTIs.
    J Antimicrob Chemother. 2015;70:1381-90.
    PubMed     Text format     Abstract available


  370. ALM RA, Johnstone MR, Lahiri SD
    Characterization of Escherichia coli NDM isolates with decreased susceptibility to aztreonam/avibactam: role of a novel insertion in PBP3.
    J Antimicrob Chemother. 2015;70:1420-8.
    PubMed     Text format     Abstract available


  371. DURAFFOUR S, Lorenzo MM, Zoller G, Topalis D, et al
    ST-246 is a key antiviral to inhibit the viral F13L phospholipase, one of the essential proteins for orthopoxvirus wrapping.
    J Antimicrob Chemother. 2015;70:1367-80.
    PubMed     Text format     Abstract available


  372. TODESCO E, Rodriguez C, Morand-Joubert L, Mercier-Darty M, et al
    Improved detection of resistance at failure to a tenofovir, emtricitabine and efavirenz regimen by ultradeep sequencing.
    J Antimicrob Chemother. 2015;70:1503-6.
    PubMed     Text format     Abstract available


  373. WILLMANN M, Bezdan D, Zapata L, Susak H, et al
    Analysis of a long-term outbreak of XDR Pseudomonas aeruginosa: a molecular epidemiological study.
    J Antimicrob Chemother. 2015;70:1322-30.
    PubMed     Text format     Abstract available


  374. SOMBORO AM, Tiwari D, Bester LA, Parboosing R, et al
    NOTA: a potent metallo-beta-lactamase inhibitor.
    J Antimicrob Chemother. 2015;70:1594-6.
    PubMed     Text format    


  375. FOURATI S, Charpentier C, Amiel C, Morand-Joubert L, et al
    Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients.
    J Antimicrob Chemother. 2015;70:1507-12.
    PubMed     Text format     Abstract available


    April 2015
  376. GOLDEN AR, Rosenthal M, Fultz B, Nichol KA, et al
    Characterization of MDR and XDR Streptococcus pneumoniae in Canada, 2007-13.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  377. RANDALL CP, Gupta A, Jackson N, Busse D, et al
    Silver resistance in Gram-negative bacteria: a dissection of endogenous and exogenous mechanisms.
    J Antimicrob Chemother. 2015;70:1037-46.
    PubMed     Text format     Abstract available


  378. AL-HATMI AM, van Diepeningen AD, Curfs-Breuker I, de Hoog GS, et al
    Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex.
    J Antimicrob Chemother. 2015;70:1068-71.
    PubMed     Text format     Abstract available


  379. HE T, Shen J, Schwarz S, Wu C, et al
    Characterization of a genomic island in Stenotrophomonas maltophilia that carries a novel floR gene variant.
    J Antimicrob Chemother. 2015;70:1031-6.
    PubMed     Text format     Abstract available


  380. GRUBER TM, Gottig S, Mark L, Christ S, et al
    Pathogenicity of pan-drug-resistant Serratia marcescens harbouring blaNDM-1.
    J Antimicrob Chemother. 2015;70:1026-30.
    PubMed     Text format     Abstract available


    March 2015
  381. LI X, Cai Q, Mei H, Zhou X, et al
    The Rpd3/Hda1 family of histone deacetylases regulates azole resistance in Candida albicans.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  382. GOLDEN AR, Adam HJ, Gilmour MW, Baxter MR, et al
    Assessment of multidrug resistance, clonality and virulence in non-PCV-13 Streptococcus pneumoniae serotypes in Canada, 2011-13.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  383. BENDER J, Strommenger B, Steglich M, Zimmermann O, et al
    Linezolid resistance in clinical isolates of Staphylococcus epidermidis from German hospitals and characterization of two cfr-carrying plasmids.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


    February 2015
  384. KARAVASSILIS V, Zarkotou O, Panopoulou M, Kachrimanidou M, et al
    Wide dissemination of linezolid-resistant Staphylococcus epidermidis in Greece is associated with a linezolid-dependent ST22 clone.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  385. KIMURA K, Nagano N, Arakawa Y
    Classification of group B streptococci with reduced beta-lactam susceptibility (GBS-RBS) based on the amino acid substitutions in PBPs.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


    January 2015
  386. STEINMANN J, Hamprecht A, Vehreschild MJ, Cornely OA, et al
    Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  387. RAYMOND S, Maillard A, Amiel C, Peytavin G, et al
    Virological failure of patients on maraviroc-based antiretroviral therapy.
    J Antimicrob Chemother. 2015;70:1858-64.
    PubMed     Text format     Abstract available


  388. LOUBET P, Charpentier C, Visseaux B, Borbor A, et al
    Prevalence of HIV-1 drug resistance among patients failing first-line ART in Monrovia, Liberia: a cross-sectional study.
    J Antimicrob Chemother. 2015;70:1881-4.
    PubMed     Text format     Abstract available


  389. DANION F, Belissa E, Peytavin G, Thierry E, et al
    Non-virological response to a dolutegravir-containing regimen in a patient harbouring a E157Q-mutated virus in the integrase region.
    J Antimicrob Chemother. 2015;70:1921-3.
    PubMed     Text format    


  390. ALEXIEV I, Shankar A, Wensing AM, Beshkov D, et al
    Low HIV-1 transmitted drug resistance in Bulgaria against a background of high clade diversity.
    J Antimicrob Chemother. 2015;70:1874-80.
    PubMed     Text format     Abstract available


  391. LAHIRI SD, Walkup GK, Whiteaker JD, Palmer T, et al
    Selection and molecular characterization of ceftazidime/avibactam-resistant mutants in Pseudomonas aeruginosa strains containing derepressed AmpC.
    J Antimicrob Chemother. 2015;70:1650-8.
    PubMed     Text format     Abstract available


  392. TODESCO E, Mercier-Darty M, Jung M, Bottero J, et al
    Ultradeep sequencing in the therapeutic management of HIV-1 infection at treatment initiation.
    J Antimicrob Chemother. 2015;70:1919-20.
    PubMed     Text format    


    December 2014
  393. MCCARTHY AJ, Harrison EM, Stanczak-Mrozek K, Leggett B, et al
    Genomic insights into the rapid emergence and evolution of MDR in Staphylococcus pseudintermedius.
    J Antimicrob Chemother. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: